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ABSTRACT 
       Excretory-secretory products (ESPs) are first characterized and defined in parasitic 
nematode proteomics studies as the combination of various biomolecules that are 
continuously excreted or secreted into the environment throughout the whole life cycle. 
ESPs are particularly interesting to many scientists as anti-parasitic vaccine candidates and 
as promising drug targets since large portions of ESPs are active enzymes that potentially 
function directly at the parasite-host or worm-environment interfaces. However, majority 
of the parasites lack whole genome sequence knowledge and genome-editing tools. Thus, 
the number of ESPs identified is limited and many functions of ES proteins cannot be 
elucidated. Therefore, we use the most studied nematode, Caenorhabditis elegans, as the 
model to characterize the composition of excreted/secreted proteins with the help of nano-
liquid chromatography coupled with tandem mass spectrometry (nanoLC-MS/MS). We 
characterized more than 509 excreted/secreted proteins with mix-staged worms, including 
many metalloproteases, cysteine proteases, and lysozymes. Proteases and proteases 
inhibitors are a major group in C. elegans ESPs. We performed stable isotope dimethyl 
labeling quantitative proteomics and compared C. elegans ESPs on different bacteria diets. 
Lysozymes are not only enriched in C. elegans ESPs but are also up-regulated in response 
to pathogen and bacteria.  
         Comparative studies of expression profiles of developmental life stages and pathogen 
infections elucidate the dynamics in regulating ESP components. We successfully 
identified stage-specific ESP groups associated with L1, L3, adult, L2 dauer, and post-
dauer. We demonstrated that proteases activities are down regulated by increased protease 
inhibitor expressions, while during dauer exit proteases expressions are increased. The 
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comparison between dauer excretome/secretome and RNA-seq dauer expression profiles 
revealed 91 ESP encoding genes that are highly expressed in dauers. We performed dauer 
formation assay to these dauer-associated gene mutants. The great prediction rate 
confirmed that our comparative method is the simplest way to quickly pick out candidates 
for functional assays. Similarly, we employed this comparative method to pathogen-
induced transcriptomes. We reported a group of genes that are associated with Serratia 
marcescens infection and a group of bacterial pathogens responding genes. We confirmed 
the roles of C. elegans ESPs in immuoregulation by infection assays with various 
pathogens. Lysosomes and cysteine protease inhibitor are among the most important genes 
in innate immune response pathway of C. elegans defending pathogen infection. 
        The recent discovery of a C. elegans sibling species, Caenorhabditis inopinata, allows 
the deeply comparative study for evolutional interpretation. The excretome/secretome of C. 
inopinata has not been characterized. We took advantage of the sensitive and high-
throughput technique of nanoscale liquid chromatography coupled to tandem mass 
spectrometry (nano LC-MS/MS) to directly characterize the protein components of C. 
inopinata excretome/secretome. Functional annotations reveal several protein families, 
including C-type lectins, Cathepsin Z, Cathepsin B family, transthyretin, and saposin-like 
families, suggesting ESPs play critical roles in regulating innate immune response. We 
compared C. inopinata excretome/secretome with C. elegans. The structures are highly 
conserved across species, suggesting the sibling species share common mechanism to 
respond to environmental stimuli.  
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C h a p t e r  1  
INTRODUCTION 
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1.1 Thesis overview 
 
Excretory/Secretory (ES) Products and the research history in parasites 
       In the nematode studies, excretory/secretory products describe the combination of a 
wide range of biomolecule that are continuously excreted or secreted out, including surface 
antigens, non-immunogenic glycolipids, glycans, bioactive lipids, heat shock proteins, 
detoxifying enzymes, surface proteases, and other metabolic products [1]–[4].  
       Excretory/secretory products in parasites have been studied for several decades now 
[5]. Parasitic nematode chronic infection to host requires successful invasion of host 
barrier, migrating through the tissue to a suitable niche and bypassing the host immune 
system to survive and reproduce [6]–[8].  Thus, the mechanism of how parasites modify 
host immune system has been studied intensively. Excretory/secretory products, as the 
active biomolecules functioning directly at the interaction surface of host and parasites, are 
at the center of the study. The investigation of excretory/secretory products will benefit the 
therapy of parasitic nematodes in many aspects. The antiallergic and anti-inflammatory 
effectors in excretory/secretory products would be great anti-parasite vaccine candidates. A 
lot of excretory/secretory products are enzymatically active proteins, providing the 
possibility of intervention with small drug molecules [9]. The featuring molecules in 
excretory/secretory products can also serve as biomarkers for early diagnosis of parasite 
infection [10].  
       The majority of the excretory/secretory products are proteins, which will be referred to 
as excretory/secretory proteins (ESPs). Most works that have been done with 
excretory/secretory products so far focus on the protein components only. The 
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excretory/secretory proteins have been characterized in the following parasites: Ascaris 
suum[11], [12], Brugia malayi[6], [11], [13] , Dirofilaria immitis[10], Meloidogyne 
incognita[9], Bursaphelenchus xylophilus[14], Heligomosomoides polygyrus[15], 
Ostertagia ostertagi[16], Ancylostoma caninum[17], [18], Strongyloides ratti[19]–[21], 
Teladorsagia circumrcincta[22][23], Trichinella pseudospiralis[24], Trichinella 
spiralis[24], Haemonchus contortus[25], [26] and Nippostrongylus brassilliensis[27]. 
However, in many of these nematodes, the numbers of identified ESPs are limited by 
several reasons. First, the main methods to characterize excretory/secretory proteins are 
functional assays like enzyme activity assay, prediction of secretion by bioinformatics, 2D 
SDS-PAGE, prediction transcriptome and proteomics [20], [26]–[28]. The numbers of 
identified excretory/secretory proteins range from 2 to 1500 and are limited by the 
characterizing method. Among these, proteomic is the most sensitive method to detect 
excretory/secretory proteins directly. High throughput proteomics also allow large scale 
protein characterization [29]. Second, genomes of many parasites have not yet been fully 
sequenced. This hinders the annotation of gene models and therefore limits the number of 
identified excretory/secretory proteins. In fact, proteins missing annotations or hypothetical 
proteins are very common in parasitic excretomes/secretomes. 
 
ESPs identified in parasitic nematodes and their immune regulation functions  
         ESPs are active directly at parasite/host interface and regulate host immunity at every 
step from initial recognition to downstream effectors [30]. The successful invasion, 
migration, and reproduction of parasites requires continuous suppression of host immune 
system by ESPs [30]–[32]. All these facts suggest that ESPs are potential anti-parasitic 
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vaccine targets to solve the emerging anthelmintic resistance [1]. Several antigens from 
ESPs are under clinical trials [33].  
       Several groups of excreted/secreted proteins have been characterized and their immune 
regulation roles have been studies intensively and their putative or partially understood 
immune regulation mechanisms are listed [11], [14], [15], [23]. 
        Proteases, including cysteine-, aspartyl-, serine-, and metalloproteinases, may be 
involved in degradation of host tissues or bacteria food, helping host invasion and/or 
nutrition uptake [11].  
        Proteases inhibitors, may function by inhibiting host proteolytic enzyme activity. 
Known protease inhibitors in parasitic ESPs include cystatins (cysteine protease inhibitor) 
and serpins (serine protease inhibitor). Proteases inhibitors could also regulate host immune 
system by blocking antigen processing. In B. malayi, CPI-2 inhibits asparaginyl 
endopeptidase (AEP) and therefore inhibits antigen processing by human B cells [34]. 
Proteases inhibitors could also regulate cytokine levels and T cell proliferation [11].  
        Antioxidants could detoxify reactive oxygen species produced by host phagocytes and 
maintain homeostasis of nematodes. Observed antioxidants in ESPs include thioredoxin 
peroxidases, peroxiredoxins, catalases, superoxide dismutases (SODs), and glutathione 
peroxidase [30].  
        C-type lectins and galectins have putative roles in many immune responses including 
antigen uptake and presentation, cell adhesion, and T cell polarization [30], [35] [36]. 
        Cytokine homologues are another group of conserved proteins in excretome/secretome. 
One most studied cytokine homologoue is B. malayi macrophage migration inhibitory 
facter (MIF). Bm-MIF mimics mammalian cytokines and could interact with human MIF 
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receptor and thus suppress pro-inflammatory activation in host [31], [37], [38], [39].   
        Although tranthyretin-like proteins are common in nematodes secretome, their 
functional role in regulating immune system remains elusive [11].  
        Heat shock proteins are another common group in secretome. One hypothesis is that 
heat shock proteins are released in the stress response pathway. There are also reports 
showing parasite secreted HSPs are antigens [11], [40].   
        Lipid binding proteins in ESPs are hypothesized to be involved in membrane 
trafficking , signaling pathways, and interaction with innate pattern-recognition receptors, 
including nematode polyprotein allergens (NPA) and fatty acid and retinol-binding (FAR) 
proteins [30]. FAR protein could bind to small lipids like vitamin A and interfere functions 
like macrophages [41].  
        Some ESPs could also be post-translationally modified, forming antigenic 
glycoconjugates. One example is a leucine aminopeptidse from Acanthocheilonema viteae, 
ES-62, heavily conjugating with an unusual phosphorylcholine moiety. ES-62 was shown 
to induce Th2 anti-inflammmatory response and suppress Th1 immune response, altering 
cytokine levels and T and B cell proliferation [30], [42]. 
 
Caenorhabditis elegans as model to study excreted/secreted proteins 
        Caenorhabditis elegans has been intensively studied as a model organism since 1963, 
leading to numerous breakthroughs in elucidating pathways and mechanisms like apoptosis, 
aging and metabolism [43]–[45]. C. elegans has a short life cycle of 3 days. It is a small 
organism with only 959 somatic cells in hermaphrodites and 1033 in males. The cell 
lineage and neuron connectome were fully mapped. The whole genome of C. elegans has 
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been fully sequenced for two decades now and benefits from laboratory work on genes and 
function characterizations.  Multiple genetic manipulation tools are available including 
RNA interference, CRISPR/Cas9 gene editing, and overexpression. Numerous functional 
and behavioral assays have already been established, making C. elegans a great model to 
study many phenomena and diseases including Alzheimer’s disease, autism, cancer, and 
aging [46]–[53].  
        However, the study of excreted/secreted proteins in C. elegans lags far behind 
compared with the works in parasitic nematodes. Researches underestimated the broad 
presence and complicated composition of excreted/secreted proteins in free-living 
nematodes. Thus, in Chapter 2, we reported proteomic characterization of C. elegans 
excretome/secretome and for the first time profiled the protein components systematically. 
We identified 509 proteins, and functions for the majority of the ESPs remain obscure. This 
work could serve as a great platform for annotating parasitic nematodes excreted/secreted 
proteins with no fully sequenced genomes or with few function annotations. Benefiting 
from the mutant’s availabilities and well-established functional characterizing techniques 
and assays, studying functions of C. elegans ESPs would provide better knowledge and 
prediction of their parasite homologues.  
         C. elegans, as a free-living nematode, undergoes four larval stages after hatch and 
reach reproductive stage in about 3 days under favorable condition [54]. Under unfavorable 
conditions, C. elegans would enter an alternative development cycle, forming non-aging 
dauer larvae that can survive for months [55]. Dauer has distinct behaviors like nictation to 
attach to other animals and disperse [56]. This phoresy phenomena is hypothesized as the 
pre-adapting step toward parasitism [7], [57], [58]. Indeed, dauer share a lot of common 
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features with parasite infective larvae, including slim bodies, a constricted esophagus, and a 
closed mouth [57]. Dafachronic acid (DA) is required in both dauer and parasites for 
dauer/infective larvae formation. This shared mechanism strongly supports that parasitism 
may be acquired from dauer to infective larvae evolution [59]–[61]. ESPs functions are the 
key to the parasite’s infections. Thus, studying the evolution of ESPs between free-living 
nematodes and parasites could provide clues for how parasitism evolved. In Chapter 4, we 
report the excretome/secretome of C. elegans sibling species, C. inopinata, to contribute to 
the collection of nematode excretomes/secretomes [62].  
        C. elegans could also be used as a great model to study the developmental regulations 
of ESPs composition [50], [63]. There are no known reports on whether specific groups of 
ESPs are up or down regulated within a certain developmental stage. Whether they are 
actively involved in the dauer decision making is unknown. In Chapter 3, we reported the 
first attempts to identify stage-specific ESPs in C. elegans.  
        C. elegans encounters a wide variety of bacteria and fungi in nature [64]. Among 
these, several bacteria and fungi have been proved to be pathogenic to C. elegans, causing 
shortened life span or non-lethal disease [65]–[68]. C. elegans ESPs are the major players 
in immunoregulation. RNAi experiments targeting several ESPs including lys-1, lys-8, cpi-
1, cpi-2, spp-5, and asp-3 showed increased pathogen susceptibility or altered life span, 
supporting the hypothesis that one major role of C. elegans ESPs is to defend pathogen 
infection [50], [69]–[71]. However, the mechanisms and corresponding ESPs of C. elegans 
responding to different pathogens are largely unknown. In Chapter 3, we identify pathogen-
specific ESPs in order to elucidate the host-pathogen interaction and to identify host 
pathways exploited by different pathogens. 
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1.2 Summary 
 
The excretome/secretome of the free-living model animal, C. elegans, had not been 
noticed and characterized. This field had long been neglected and scientists underestimated 
the complexity and evolutional importance of C. elegans ESPs.  
Thus, in Chapter 2, with the sensitive and high throughput proteomic method, we for 
the first time systematically profile the protein components of C. elegans 
excretome/secretome. Functional annotation of ESPs revealed the presentence of several 
important protein families, including proteases, proteases inhibitors, lectins, lysozymes, 
superoxide dismutase, and peroxidases. We predicted functions for ESPs, including 
bacteria/pathogen defense, immune system regulation, response to stimuli, and nutrition 
uptake. We also for the first time demonstrate that the proteases and proteases inhibitors in 
ESPs are enzymatically active in vivo.  
Quantitative proteomic method was employed to profile excretomes/secretomes under 
different temperatures and bacterial diet exposure. This is the first attempt to study the 
dynamic regulation of C. elegans excretome/secretome. We show under different 
temperatures that the main structures of the excretome/secretome remain stable. Upon 
exposure to pathogenic bacteria, lysozymes are highly up-regulated to defend against toxic 
effects.  
In Chapter 3, we take a further step to push the comparative method to a broader 
application, taking advantage of the deeply sequenced C. elegans transcriptomes of 
different developmental stages. Clustering revealed the stage-specific ESPs. Dauer-specfic 
ESPs are of particular interest due to the similarities between dauer and parasite infective 
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larvae. To provide a cross-reference to our prediction method, we directly characterized 
dauer ESPs with Mass-Spec. The most interesting observation is that proteases inhibitors 
are up-regulated in dauer formation and proteases are up-regulated in dauer exit, suggesting 
that protease activity level maybe be related with dauer decision making.  
Pathogen-specific ESPs are revealed by clustering the pathogen-exposed 
transcriptomes. We validated our prediction by multiple infection assays. The results 
showed our method is the quickest way to select out candidate genes for functional assays. 
In Chapter 4, we characterized the protein components of the C. elegans sibling 
species, C. inopinata. This provides a great example of how C. elegans ESPs facilitate the 
annotation to the gene model of a new species. The comparisons between species showed 
protein families are conserved in excretome/secretome. Thus, the knowledge of ESPs in C. 
elegans can be used to annotate the poorly understood genome or excretome/secretome in 
parasites.  
In summary, the characterization of C. elegans ESPs is the first study towards free-
living nematodes excretome/secretome. How C. elegans responds to environmental 
changes is unclear and a large portion of identified ESPs has unknown functions. Our work 
provides a solid basis to study the mechanisms and signaling pathways of how C. elegans 
maintains homeostasis. Also, our work would be useful to help annotate poorly understood 
parasitic excretome/secretome based on homologies. It also enables the comparison with 
available parasites excretomes/secretomes, providing clues for how parasitism evolves.   
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PROTEOMICS PROFILING AND FUNCTIONAL 
CHARACTERIZATION OF CAENORHABDITIS ELEGANS 
EXCRETOME/SECRETOME 
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2.1 Abstract 
 
       Excretory-secretory proteins (ESPs) are first characterized and defined in parasitic 
nematode proteomics studies as the combination of various biomolecules that are 
continuously excreted or secreted into the environment throughout the whole life cycle. 
ESPs are particularly interesting to many scientists as anti-parasitic vaccine candidates and 
as promising drug targets since large portions of ESPs are active enzymes that potentially 
function directly at the parasite-host or worm-environment interfaces. ESPs are also 
reported to play pivotal roles in many critical pathways, regulating nematode survival, 
reproduction, food processing, and innate immune response. However, proteomics studies 
using parasitic nematodes as models are limited due to lack of whole genome sequence 
knowledge and lack of genome-editing tools. Thus, the number of ESPs identified is 
limited and many functions of ES proteins are elusive. Therefore, we use the most studied 
nematode, Caenorhabditis elegans, as the model to characterize the composition of 
excreted/secreted proteins with the help of nano-liquid chromatography coupled with 
tandem mass spectrometry (nanoLC-MS/MS). In summary, we characterized more than 
509 excreted/secreted proteins with mix-staged worms, including many metalloproteases, 
cysteine proteases, and lysozymes. With gene ontology analysis, many proteins are 
annotated to play roles in defending bacterial infection and regulating pathogen 
susceptibility. Proteases and proteases inhibitors are a major group in C. elegans ESPs. We 
performed stable isotope dimethyl labeling quantitative proteomics and compared 
Caenorhabditis elegans excretomes/secretomes on different bacteria diets. Lysozymes are 
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not only enriched in C. elegans ESPs but are also up-regulated in response to pathogens 
and bacteria.  
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2.2 Introduction 
 
Many parasitic worms are associated with severe diseases, infecting people, animals, 
and plants and causing heavy economic burdens around the world [1]–[3]. For example, 
Echinococcus granulosus is responsible for Cystic hydatid disease (CHD) [4], [5]. Filarial 
parasites are the cause of Lymphatic filariasis (LF) [6]. Pine wood nematode 
Bursaphelenchus xylophilus is a notorious forest pest, causing pine wilt disease [7]. Data 
has shown that 1334 million people are at risk of parasitic nematodes infection and 3 
billion dollars is spent each year on parasitic worm-related diseases treatment or prevention 
[2]. Excretory-secretory (ES) products are a wide range of biomolecules, primarily 
proteins, which are continually excreted and secreted from nematodes through all life 
stages [1], [8]–[10]. ESPs of parasitic worms have attracted the attention of many 
researchers for decades as pathogenicity factor candidates. Upon infection, parasitic 
nematodes need to penetrate tissue barriers and migrate through the host tissue to a suitable 
niche while evading host immune defenses [1]. ESPs are believed to mediate this complex 
process and function by regulating the host immune system, allowing parasites to 
successfully invade and reproduce inside or transfer between hosts. Complex components 
of ESPs, including hundreds of different proteins, have multiple functions regarding  
modulation of signaling pathways, nutrient transport and/or uptake, digestion, blood 
coagulation, and so on [2], [7], [11]–[14]. 
All these facts address the importance and urgent requirements for more knowledge of 
these physiologically and clinically important biomolecules. Many parasitic nematodes 
even develop comprehensive and highly specific-host-dependent life stages during the long 
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history of adaptation and co-evolution [11]. Differences in protein excretion/secretion 
among nematodes may relate to the ecological niche of each parasite and the pathological 
changes that they induce. A better understanding of how these specific interactions take 
place and how they achieve precise control and biological function clearly requires more 
study of the nematodes excretome/secretome. The excresome/secretome is important for 
cell communication, cell adhesion, and interaction with the environment. During 
development, secreted proteins are essential for cell fate specification and cell migration 
[12], [14], [15]. 
ESPs are active directly at the interface between nematodes/environment and 
parasite/host. Many proteases are included and play a pivotal role with their catalytic 
activities. Proteases in ESPs are great candidates for potential new drug targets for 
intervention and vaccine design, especially considering the ongoing resistance problem 
with current anti-parasite drugs [16]–[20] . 
Recently, with the benefit of high-throughput proteomic technology coupled with 
developing genome and transcriptome sequencing, several proteomic studies have been 
done in different parasite-animal models, providing rich information on parasitism in 
different species [11], [21]–[24]. The ESPs profiles have been identified from Brugia 
malayi, the canine hookworm Ancylostoma caninum, the plant parasitic nematode 
Meloidogyne incognita, and from Strongyloides ratti [11], [25], [26][26], [27]. However, 
not all of these nematode datasets were analyzed against complete genomes (or 
transcriptomes). Some of the compilations are less completely assigned than others, which 
hinders the comparison between nematodes species. Additionally, only a limited number of 
secreted proteins have been cloned and characterized. Limited knowledge regarding the 
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molecules involved in the pathology as well as lack of techniques for functional analysis in 
parasitic nematodes greatly restricts the ability to elucidate the molecular mechanisms of 
pathogenicity [26]. 
Thus, excretory-secretory products of C. elegans were completely profiled using 
proteomic analysis and would provide insights to the molecular basis of how C. elegans 
adapt to changes in the environment.  
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2.3 Results 
 
Characterization of C. elegans Excreted/Secreted Proteins (ESPs) using nanoLC-
MS/MS 
       The complete content of C. elegans ESPs remains unknown to date. Proteomic 
analysis, at present, is the most powerful and successful approach in directly identifying a 
large set of secreted proteins. A large-scale identification of secreted proteins using nano-
liquid chromatography coupled with tandem mass spectrometry (nanoLC-MS/MS) analysis 
was used in this study, characterizing the ESP profile of C. elegans with good quality.  
       C. elegans wild type N2 strain was cultured in liquid culture using E. coli HB101 as 
food source. Initial concentration of 3 worms/µl was used in a 250 ml S Medium system 
and worms were grown at 20°C for 7 days. Mix-staged nematodes were then harvested by 
centrifuge and washed intensively six times in M9 buffer. Worms were left in 1 ml M9 
buffer for incubation at 20°C for another 4 hours. Supernatant was collected and filtered by 
a 0.22µm syringe filter unit and treated as the unconcentrated C. elegans Excreted/Secreted 
Proteins. C. elegans ESPs sample was further digested by lysine/trypsin and subjected to 
nano LC-MS/MS for peptide characterization (Figure 2.1).   
       The number of C. elegans proteins identified in one single test is fairly sensitive to the 
quality of prepared excretome/secretome sample (low background contaminating peptides 
noise, high reading depth), ranging from 395 to 637 secreted/excreted proteins. As shown 
in Figure 2.2, 228 proteins were identified in four biological replicates and 605 proteins 
were shown up in at least 2 out of 4 replicates. We further excluded proteins that were 
identified less than 2 times by MS/MS, reducing the set to 509 proteins. We treated this 
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subset of 509 proteins as a confident profile of C. elegans ESPs and majority of proteins 
were also identified with two or more specific peptides (Figure 2.2). The detailed 
composition of ESP is provided in a concise form in Appendix Table 2.1, which provided 
details for mass-spec readout of these 509 C. elegans secreted/excreted proteins (Appendix 
Table 2.1). This confident subset of 509 proteins was further used in subsequent functional 
annotations.  
        These numbers of ESPs identified in Mass-Spec are comparable with earlier parasites 
secretome data: a proteomic study with Strongyloides ratti identified 586 proteins in total 
and 852 proteins were characterized in Brugia malayi ESPs [25], [26]. With continually 
refining and experimentally verification after publication of the first draft of 
Caenorhabditis elegans genome, 20,242 protein-coding genes are now included in the 
release 210 of WormBase (http://www.wormbase.org) [28] . Our data covered about 2.5% 
(509 out of 20,242) of the whole worm protein-coding genes.  
 
Identified C. elegans ESPs were annotated to be secreted  
      We first searched the whole list of C. elegans ESPs against UniprotKB for secretion 
information. 25 proteins that were manually annotated to be secreted were listed (Table 
2.1). As we expected, aspartic proteases like asp-6 and asp-3, zinc metalloproteinase were 
important proteinases that may mediate critical substrate processing for nutrient uptake. 
Transthyretic-like protein family members were reported to be key extracellular proteins 
with immunomodulatory potential [2]. This knowledge strongly supports that the identified 
C. elegans ESPs are collected from secretion with biological meanings.  
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      The prediction of a signal peptide is typically used as a first filter to identify secreted 
proteins [29]. Thus, we examined the presence of signal peptide and location of signal 
peptide cleavage sites in C. elegans ESPs using SignalP5.0 [30]. 368 out of 509 proteins, 
which represented 72.3% of the whole list of C. elegans ESPs, were predicted to contain a 
signal peptide. This suggested that the majority of identified proteins were very possibly 
secreted. The proportion of the identified proteins bearing a secretion signal was higher 
than the percentage of signal peptide containing proteins in reported literature on other 
nematodes: B. malayi (55%) and B. xylophilus (41%) [7], [25]. 
       The remaining 27.7% proteins may have unknown secretory signals or lack of a 
classical signal peptide, or may be secreted through non-classical secretory pathways. In 
parasitic nematodes, thioredoxins and macrophage migration inhibitory factor homolog in 
B. malayi were proven to be exported despite lacking a signal peptide [31], [32] . Helminth 
parasites were shown to produce exosome, carrying immunoglobulins and metabolic 
enzymes [33]–[36]. Exosome proteome of E. caproni even explained 54% of the 
characterized secretome [37]. Thus, non-canonical secretion mechanism might be a 
common feature in nematodes [37]. 
        Next, since C. elegans genes have been intensively studied for several decades, we did 
a further search in WormBase, collecting all expression data (Appendix Table 2.2). We 
then examined the cell/tissue enrichment to find which anatomical parts are statistically 
over-represented (Figure 2.3). As shown in Figure 2.3, the intestine is the most enriched 
tissue source of C. elegans ESPs, suggesting a large portion of ESPs may regulate food 
processing and nutrient uptake. C. elegans, as a free-living nematode, mainly interacts with 
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bacteria. The intestine is the major location to interact with outer environment, including 
processes related to food digestion and defending against harmful bacteria or pathogens.  
      Several genes even have published fluorescent protein reporter lines of expression 
patterns. The C. elegans ESPs are expressed in intestine, excretory cell and gland cell, 
amphid sheath cell, hypodermis and uterine epithelial cell and more [38], [39]. The C. 
elegans excretory system in C. elegans contains four cells: pore cell, duct cell, canal cell, 
and a fused pair of gland cells [40]. The excreted/secreted materials pass gland and canal 
cells and are deposited outside through duct cell [41]. The published expression patterns 
once more confirmed that the proteins identified in proteomics of C. elegans ESPs were 
secreted/excreted.  
 
Cellular components contaminations were inevitable yet controlled at reasonable level 
in C. elegans ESPs  
      Major contamination of the results comes from the E. coli food that was used during the 
culture of worms. In preliminary Mass-Spec runs, 70% of identified proteins were of E. 
coli origin. To solve this problem, liquid culture of C. elegans was harvested after 7 days 
when no obvious food trace could be observed. Worms were washed intensively 6 times to 
further remove bacteria attached to worm surface or defecated from worm body. After 
optimization of the whole workflow, each Mass-Spec run only contained less than 10 
proteins of E. coli origin. 
       Another major source of contamination came from the lysate of dead worms. A drop of 
liquid culture was examined carefully under a compound microscope before harvesting the 
nematodes. Only cultures with living worms and without other fungal or bacterial 
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contamination were used in subsequent incubation and Mass-Spec sample preparation. 
Enzyme digestion (like trypsin) and MS sample preparation steps may also have introduced 
contaminating proteins, yet these proteins can be easily identified and excluded from the 
final annotation of the results. 
      As shown in Appendix Table 2.1, some cellular proteins, for example, ribosomal 
proteins and actins, are included in C. elegans ESPs. These may at first sight be considered 
as contaminates from worm lysate. However, we carefully checked the viability of worms 
before sample collection and minimized the effects of worm lysate. The parasitic 
nematodes excretome/secretome also have lots of ribosomal proteins and actins [7], [11], 
[25]. The control done with whole worm lysate confirmed that ribosomal proteins and 
actins are bona fide ESPs [7].  
 
Brief overview of C. elegans Excretome/Secretome structure shows several protein 
families are main players 
       The most abundant proteins identified in C. elegans ESPs under the standard culture 
condition were listed (Table 2.2). C. elegans excretome/secretome shared many proteins in 
common with other nematodes secretome, including lysozyme family members, small heat 
shock proteins, aspartic proteases, cystatins (cysteine protease inhibitors), serine protease 
inhibitors (serpins), lectins, and transthyretin family proteins [7], [25]. The common 
features among species indicated that the conservation and potential evolution relationships 
during parasitism acquisition could be elucidated through comparing C. elegans 
excretome/secretome data with ESPs from other nematodes. 
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Gene Ontology analysis  
       Another main purpose of ESPs study in C. elegans is to utilize the 
excretome/secretome data collected in the Mass-Spec experiment and to transform it into 
rich information of clues and guides for following functional characterization for individual 
protein entry. One obvious and critical challenge is to bring order into this overwhelming 
amount of data. Gene Ontology has had a great success in developing precise terminology 
that can be used across many different species, providing structured means to describe the 
biological processes, cell components, and molecular functions of gene products. The 
precise role of ES proteins from parasitic nematodes in mediating cellular processes is 
largely unknown due to the lack of knowledge in function annotation. However, the best 
currently available genome annotation with C. elegans has a great advantage in explaining 
functions of excretory/secretory proteins.   
       We conducted Gene Ontology (GO) term analysis to the list of 509 excreted/secreted 
proteins, using the whole worm genome data as the reference background. Thus, we could 
examine the relative abundance of secreted proteins and detect whether the secreted 
proteins are enriched in the excretome/secretome result. A considerable amount of software 
for ontological analysis of gene lists has been published over the past 5 years, each of them 
having advantages and drawbacks and each approaching data or vocabularies in a slightly 
different manner. Gene Ontology Consortium (powered by PANTHER, 
http://geneontology.org) [42]–[46] and the Database for Annotation, Visualization and 
Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov) [47], [48] are among some of 
the most well-known tools. We used both tools here to examine our Mass-Spec data, which 
gave back similar annotations. The GO analysis results shown below are generated with the 
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former tool. The 509 proteins with gene id information were submitted under GO analysis, 
with 508 proteins successfully annotated with 1 unmapped WormBase gene id. Also, the 
top 50 most abundant proteins identified in the preliminary result were submitted to similar 
analysis as well to assure the validation of this method. 
      PANTHER overrepresentation test was performed to GO terms of cellular component 
annotation with Fisher’s exact test and corrected by calculating false discovery rate [43]. 
Over or under represented GO terms of cellular component were listed (Table 2.3). The 
enriched GO terms are associated with secretion or suggest proteins are presenting at 
surface, as most enriched cellular components are found to be vesicle lumen 
(GO:0031983), membrane raft (GO:0045121), vacuole (GO:0005773), lysosome 
(GO:0005764) or extracellular region (GO:0005576) (Figure 2.4). Genes with GO terms 
associated with some level of secretion explained almost half of the whole gene list, 
strongly supporting the conclusion that the proteins characterized in Nano LC-MS/MS are 
from secretion.  
      A similar test was performed with biological process GO terms. Clearly, several major 
subgroups can be identified from the biological process GO term list. The first group 
contains peptidoglycan metabolic process (GO:0000270), peptidoglycan catabolic process 
(GO:0009253), glycosaminoglycan catabolic process (GO:0006027), cell wall 
macromolecule catabolic process (GO:0016998), glycosphingolipid catabolic process 
(GO:0046479), glycolipid catabolic process (GO:0019377), chitin metabolic process 
(GO:0006030), glucose metabolic process (GO:0006006), aminoglycan catabolic process 
(GO:0006026). These GO terms indicate C. elegans ESPs may involve in regulating the 
surface glycan modification, surface galectin presentation, and surface coat synthesis. 
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Surface glycan and galectins are key molecules in interacting with binding and invasion of 
environmental bacteria and pathogens. The second group contains gland morphogenesis 
(GO:0022612), gland development (GO:0048732), and pharyngeal gland morphogenesis 
(GO:1905905). This finding is consistent with our hypothesis that the C. elegans excretory 
system and head sensory neurons are continuously secreting proteins to facilitate food 
uptake and chemical sensing, therefore modifying nematodes’ behavior according to 
environmental signals. The third group of biological process GO terms includes defense 
response to Gram-positive bacterium (GO:0050830), response to superoxide 
(GO:0000303), innate immune response (GO:0045087), and defense response to Gram-
negative bacterium (GO:0050829). This is consistent with our expectation that excretory-
secretory proteins are capable of regulating immune responses and helping nutrition uptake 
or removing pathogens/cell debris, probably through lysosome and phagolysosome. The 
fourth group includes response to oxygen radical (GO:0000305), response to external biotic 
stimulus (GO:0043207), response to other organism (GO:0051707), and response to biotic 
stimulus (GO:0009607). This subset of ESPs again confirmed the critical role of ESPs in 
response to stimuli, thus adapting to the changing environment. Moreover, proteolysis 
(GO:0006508) and regulation of proteolysis (GO:0030162) are also well represented in C. 
elegans ES products, supporting the earlier assertion that many of the ES proteins are 
enzymatically active, playing important roles in regulating biological activity and 
metabolism. On the other side, GO terms depleted in Mass-Spec result support the 
conclusion that the data collected were truly from secretion once more.  The 
underrepresented biological process GO terms mainly contain nucleic acid metabolic 
process (GO:0090304), regulation of transcription, DNA-templated (GO:0006355), and 
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regulation of RNA biosynthetic process (GO:2001141). These are mainly terms associated 
with proteins that function inside the nuclei (Figure 2.5 and Table 2.4).  
      GO terms enriched in molecular function (Figure 2.6 and Table 2.5) are mainly 
lysozymes and proteases and proteases inhibitors, including galactosidase activity 
(GO:0015925), serine-type exopeptidase activity (GO:0070008), lysozyme activity 
(GO:0003796), peptidoglycan muralytic activity (GO:0061783), threonine-type peptidase 
activity (GO:0070003), nutrient reservoir activity (GO:0045735), aspartic-type 
endopeptidase activity (GO:0004190), cysteine-type endopeptidase activity (GO:0004197), 
serine hydrolase activity (GO:0017171), endopeptidase inhibitor activity (GO:0004866), 
and serine-type endopeptidase inhibitor activity (GO:0004867). GO terms depleted in 
Mass-Spec result included nucleic acid binding (GO:0003676), DNA-binding transcription 
factor activity (GO:0003700), ion channel activity (GO:0005216), and transcription 
regulator activity (GO:0140110). Proteins related with these activities are usually believed 
to function in cellular or nuclear parts, with less possibility to be found in 
excretome/secretome in C. elegans.  
 
KEGG and reactome pathway analysis  
      KEGG and reactome pathway analysis were performed to identify pathways that are 
over-represented in C. elegans ESPs (Figure 2.7 and Figure 2.8) [49]–[52] . Innate 
immune system pathway and protein degradation pathway are the most over-represented 
pathway, suggesting one major role of C. elegans ESPs is to continuously fight with the 
changing surroundings, specifically defending infection of bacteria pathogens.  
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Pfam domain search and InterProScan sequence search 
      Each protein sequence in C. elegans excretome/secretome data was also searched 
against Pfam and InterPro database (Figure 2.9 and Figure 2.10) [53], [54]. Each protein 
sequence was also BLASTed against each other, and the BLAST plot was made based on 
the similarity between sequences (Figure 2.11).  Key features and enriched protein 
domains can provide information to the ESPs functions. We could also gain better 
understanding of the structure of C. elegans ESPs by knowing what the major protein 
families in the result are. C-type lectins, aspartic peptidases (peptidase A1), serine 
peptideses (peptidase S10), cysteine proteases (peptidase C1), and transthyretins are the 
major protein families in C. elegans ESPs. Protein-protein interactions were also plotted by 
STRING (Figure 2.12) [55]. Cathepsin Z family and Cathepsin B family members are the 
cores to interact with other ESPs.  
 
Proteases and proteases inhibitors in ESPs are enzymatically active  
      Peptidases contribute to host specificity, host range, and virulence [7], [25].To detect 
putative proteases (also termed peptidase or proteinases) and proteases inhibitors, a 
MEROPS batch BLAST search (http://merops.sanger.ac.uk) was performed as an 
additional approach besides GO terms [56]. A total of 509 secreted protein sequences were 
subjected to the MEROPS BLAST search and classified into detailed MEROPS proteases 
or proteases inhibitor families (E-value cutoff of 1e-4). This approach predicted 88 putative 
proteases and 87 proteases inhibitors, contributing to 34.4% of annotated genes in list. The 
percentage of peptidases in the B. xylophilus secretome was 10.6%, whereas in M. 
incognita and B. malayi they were 6.4% and 5.2%, respectively [7], [25]. 
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       Carbohydrate-active enzymes (CAZymes) are key regulators to metabolism of 
glycoconjugates, oligosaccharides, and polysaccharides. The size and diversity of 
CAZymes can provide clues to nematode nutritional strategy and host specificity. dbCAN 
(automated CAZyme annotation) database was searched to identify CAZymes in C. 
elegans ESPs [57]. With HMMER3 search, 17 glycoside hydrolases (GH) were identified 
in C. elegans ESPs, belonging to 11 GH families (Table 2.6).  
      We directly examined in vivo enzyme activities of candidate C. elegans proteases and 
proteases inhibitors using utse (uterine seam cell) development model. Utse (uterine seam 
cell) has proven to be an excellent system to study cell outgrowth defects. During the L4 
stage, utse undergoes cell outgrowth and nuclear migration. The cell body grows 
bidirectionally along the anterior-posterior axis and nuclei segregate into two groups, 
migrating and settling at the edges of the utse cell body. Both arms will reach final shape at 
L4 lethargus stage [58]. Utse is very sensitive to levels and activities of a series of complex 
regulators, including two astacin metalloproteases, nas-21 and nas-22. Astacin family 
members are highly conserved in functions while nas-20 and nas-31 were detected in 
excretome/secretome. Additionally, one speculated ESPs function is to regulate tissue 
migration during host invasion, sharing a common feature with cell outgrowth and 
migration during in vivo development and with metastatic cancer spreading tumors from 
one tissue to another. Thus, utse would serve as a great platform to observe the effects of 
proteases or protease inhibitors. Generally, using RNA interference (RNAi) to target 
proteases might lead to the failure of cell outgrowth in utse while RNAi targeting protease 
inhibitors would cause overgrowth of cell body [58].  
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      We screened 44 RNAi strains targeting selected genes from ESPs data with a putative 
protease or protease inhibitor function. Uste cell body was labeled with mCHERRY and 
nuclei of utse were labeled with GFP to allow tracking of the morphology of the utse cell. 
Defects in utse development, including shortened outgrowth of utse arms, incorrect 
migration of cell nuclei, were scored and recorded (Figure 2.13 and Table 2.7). Among 
these genes, clec-15, ttr-16, ttr-17, and mig-6 resulted in a pretty high rate of deficiencies of 
animals with a ratio of 50%, 60%, 40%, and 60%, respectively. Another 12 strains have 
around 20% defect rates. Indeed, we observed the failure of development in utse arms with 
proteins that have protease activities (example of cpr-1). Also, arms with abnormal shapes 
were observed with RNAi result targeting protease inhibitors. We calculated the p-values in 
comparison to the empty vector (RNAi) using Fisher’s exact test. 7 genes (8 stains, both 
mig-6 strains passed p <0.05) in total are within the p<0.05 threshold (clec-15, cpi-1, ttr-16, 
ttr-17, cpi-2, asp-6, mig-6). These genes passed FDR test at 0.05 as well. (The positive rate 
is 8/44 = 0.0182, giving a new alpha equal to 0.009.) 
      Thus, proteases and proteases inhibitors contribute to a big portion in C. elegans ESPs. 
The RNAi targeting proteases and proteases inhibitors lead to cell outgrowth deficiency, 
directly confirming proteases and proteases inhibitors are enzymatically active in vivo. This 
fact makes studying proteases and proteases inhibitors even more interesting since it 
provides the possibility to interfere with the enzyme activities using small drug molecules. 
In other parasitic nematodes, several proteases were also proven to be active and disruption 
of protease activity would cause failure in parasites infection.  
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Culturing worms at different temperatures does not change the majority of C. elegans 
ESPs 
       We established the standard protocol to perform proteomics study of C. elegans ESPs. 
By changing the culturing conditions, we could detect C. elegans ESPs using same 
technique but expect the composition of new ESPs was modified according to the cultural 
condition. Therefore, comparison of ESPs under different conditions would allow quick 
selection of candidate genes for subsequent large-scale reverse genetic experiments. Here, 
we employed stable isotope dimethyl labeling quantitative proteomics since it is the most 
quick, easy, and affordable comparative Mass-Spec method.  
        The standard protocol for proteomics characterization of C. elegans ESPs was 
performed to a mix-staged population of nematodes culturing at 20°C on an Escherichia 
coli HB101 diet.  
        15°C - 25°C temperature range is the physiological condition for C. elegans growth. 
Temperature beyond this range would have harmful effect to nematode development [59]. 
C. elegans N2 strains were cultured and harvested worms were incubated at 15°C, 20°C 
and 25°C respectively. Scatter plots of pair-wise proteomics results showed that the 
majority of ESPs components intensities remain stable between comparisons of 15°C to 
20°C and 20°C to 25°C (Figure 2.14 and Figure 2.15). 
 
Lysozyme expressions are up-regulated in C. elegans Excretome/secretome upon 
exposure to pathogens and different bacteria diets  
       Strikingly, almost all known C. elegans behaviors are affected by food [59]. Literature 
has shown that different food diets greatly affect and shape the metabolism of this free-
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living soil nematode [59]–[62]. Additionally, more than a third of the putative secreted 
proteins are up-regulated upon exposure to pathogens, indicating that a substantial fraction 
may have a role in immune response [63]. We also performed phenotype enrichment 
analysis to C. elegans ESPs (Figure 2.16). The top three categories are all very interesting. 
The top 1 enriched phenotype is “avoids bacteria lawn”, indicating the roles of 
immunoregulators in response to bacteria and pathogens. The second most enriched 
phenotype is “dauer constitutive”. Dauer stage is usually considered to be equivalent to the 
parasite infective larvae. Infective juveniles are the most active stage for 
excretory/secretory proteins to function, mediating successfully invasion and migration into 
host. The C. elegans ESPs associated with dauer phenotype would lead to interesting 
comparison between dauer and infective larvae. The third most enriched phenotype is 
“molt variant”, indicating ESPs may play pivotal roles in molting process. ESPs are 
supposed to function at critical transition of life styles, including molting process. Earlier 
ES results in Brugia malayi showed molting larvae continuously secreting immune system 
regulators, including leucyl aminopeptidase (ES-62) and galectins [25]. All these evidences 
lead to the conclusion that the composition of ESPs is actively regulated and is adapted to 
the changing environment.  
        Thus, in order to explore the metabolism changes adapting to different bacteria diets, 
we cultured the C. elegans on the following bacteria: E. coli HB101, E. coli OP50, Bacillus 
subtilis, Bacillus mycoides, Bacillus simplex, Bacillus megaterium, Microbacterium 
nematophilum CBX102.   
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        The differences between two E. coli diets, HB101 and OP50, were not very 
significant, while the majority of protein components were detected at similar level (Figure 
2.17).  
        Bacillus bacteria are common soil bacterium. While Bacillus subtilis has a similar 
nutrition content as E. coli, Bacillus simplex and Bacillus megaterium are known poor 
quality food to support nematode growth [59], [64]. E. coli is not a soil bacterium that C. 
elegans would encounter in the natural habitat. Thus, excretome/secretome profiling of C. 
elegans on soil bacteria may be a better representation of the wild status of C. elegans 
metabolism.  
         However, the qualities of proteomics on bacteria diets were not comparable to ESPs 
feeding on E. coli. The technical difficulties mainly come from the interference of 
contamination proteins. First, bacteria strains are much stickier than E. coli and were hard 
to fully be depleted and removed simply through wash steps in sample preparation. 
Microbacterium nematophilum is even a pathogen to C. elegans, forming bumps and 
attaching to the anal part of worms [65]–[68]. Thus, the number of contamination proteins 
of bacteria source increased significantly in the final proteomic results. Second, C. elegans 
cultured on bacteria food had a higher death rate and released cellular proteins to the 
culturing system. Thus, the number of non-secreted proteins was increased. The 
comparisons were further hindered by the complexity of excretome/secretome as well as 
the great variations among replicates. 
          We were able to detect several proteins that are highly up-regulated when 
challenging with poor-quality food or pathogen (Table 2.8). Among these proteins, 
lysozymes were up-regulated by the most. ilys-2 has a 188-fold change with feeding with 
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Bacillus subtilis and a 1155-fold change when feeding with Bacillus mycoides. To validate 
the transcriptional level change of lysozymes, we performed quantitative Real Time 
quantitative PCR (RT-qPCR) to ilys-2 and ilys-3. Indeed, ilys-3 was up-regulated by 4.45 
fold when feeding on Bacillus subtilis and up-regulated by 3.92 fold when feeding on 
Bacillus mycoides. ilys-2 was up-regulated by 23.88 fold when feeding on Bacillus subtilis 
and up-regulated by 35.29 fold when feeding on Bacillus mycoides (Figure 2.18). This 
result strongly supports that C. elegans ESPs composition is under regulation and is 
adapted to the environment. Lysozymes as the main antimicrobial molecules are up 
regulated in response to defending bacteria and pathogens. 
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2.4 Discussion 
 
       Several proteomics studies of excreted/secreted proteins in parasitic nematodes have 
been published, resolving proteins from a couple hundreds to even one thousand. Several 
secreted proteins, like ES-62, have been proven to play pivotal roles for the infective larvae 
to invade host by simple infection assays [25]. Proteases from cathepsin B and Z families 
have been shown to be enzymatically active in vitro [69], [70] . All the successes in 
studying the parasites ESPs greatly contribute to the identification of new anti-parasite 
vaccines or provide candidates to small drug molecule designs. However, the successes are 
limited at multiple aspects. First, only a couple of parasitic nematodes have a fully 
sequenced and annotated genome. The excretome/secretome of many parasites, for 
example, bovine lungworm Dictyocaulus viviparous, were identified by searching against 
expressed sequence tag (EST). This limits the number of excreted/secreted proteins that can 
be identified and also introduce errors in annotating the proteins. Second, the annotation 
level of parasites genome is very limited. It is really hard to find annotations beyond 
sequences and there are very little reported expression patterns and phenotype information. 
In fact, many parasites excretome/secretome were annotated based on C. elegans BLAST 
homologs. Third, the functional characterizations of parasite ESPs are limited. Many 
techniques, including genome-editing tools including CRISPR, gene overexpression by 
microinjection, gene expression knockdown by RNAi, and gene knockout, are not available 
in parasitic nematodes studies. In proteomics papers of parasitic ESPs, many can only 
identify less than 100 proteins with very few annotations to the proteins [16], [71]. The 
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functional assays are hard to develop as well due to the difficulty to generate homozygous 
gene mutants. This is harmful to elucidate excreted/secreted protein functions.  
        C. elegans, one of the free-living nematodes, has been the first and most studied 
nematode for several decades. However, no one has reported the proteomics profiling of 
excreted/secreted proteins in C. elegans. People have underestimated the importance and 
complexity of C. elegans ESPs all the time. Our proteomics result is the first report to fully 
characterize the protein components of C. elegans excretome/secretome. 509 proteins were 
identified through nanoLC-MS/MS. This number is astonishing at first glance, since no one 
has expected a free-living nematode would have such a complicated excretome/secretome 
composition. When we think about the fact that even free-living nematodes are facing the 
continuously changing environments and need to respond to stimuli actively to achieve 
successful survival in the niche, this number is reasonable. Also, the number of identified 
C. elegans ESPs is comparable to the parasite ESPs, indicating the ESPs across nematodes 
may be evolutionally conserved. Our proteomic result provides the basis to allow 
comparison between C. elegans and parasitics nematodes. The knowledge learned in C. 
elegans ESPs could be transferred to predict protein function and help functional assay 
design and drug design in the future.  
       Thus, we can take advantage of the thoroughly annotated C. elegans genome and 
available Gene Ontology tools to find the major protein families in ESPs. We first prove 
that the majority of proteins detected in proteomics are from secretion. Most ESPs are 
expressed in the intestine and may be related to food digestion and stimuli response. Our 
result stressed the importance of lysozymes, lectins, proteases, and protease inhibitors.  
Lysozymes and lectins function as the immune system regulators. They are the key players 
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in facilitating defending bacteria/pathogens and nutrition uptake. Protease and protease 
inhibitors are a big group in C. elegans ESPs (Figure 2.19). The abundance and varieties of 
protease species allow the processing of a wide range of substrates, ensuring the successful 
survival in a complex niche. The enzyme activity gains particular interest of many 
scientists since it opens the possibly to interrupt enzymatically activity by small molecules. 
Indeed, we proved proteases and proteases inhibitors are active in vivo. With the advanced 
gene manipulation techniques and the abundant mutant libraries in C. elegans, many 
functional assays can be designed and tested in the future.  
        After the successful establishment of standard protocol of characterizing C. elegans 
ESPs, we performed the stable isotope dimethyl labeling proteomics to allow comparison 
of ESPs collected under different conditions. The composition of ESPs is fast changing and 
highly dynamic. It is under accurate regulation and is responding to the stimuli and 
adapting to changing environment all the time. We have shown the major protein families 
remain stable when increasing the culturing temperature although there is a slightly 
tendency to increase expressions of genes related to defense pathway. When challenging 
the nematodes with different bacteria and pathogens, the lysozymes are highly expressed. 
We further validated this result by RT-qPCR and transgenetic promoter reporter lines. The 
comparative proteomics greatly narrow down the candidate gene sets to be tested in 
functional assays. 
      Other useful comparative datasets could be generated by using C. elegans of different 
stages or by separating hermaphrodites and males of C. elegans.  This comparison would 
give information of ESPs associated with different life styles and genders. Since parasites 
have more complicated lifestyles and require transfer between host species, stage-specific 
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ESPs will provide insights towards the mechanisms of nematodes life stage transition. The 
ESPs associated with specific genders may facilitate the study of how males and 
hermaphrodites recognize and attract to each other in nature.  
       Using C. elegans mutants can generate useful comparative datasets as well. For 
example, since we have shown C. elegans ESPs include glycan-processing enzymes and 
lectins, srf mutants may be a good candidate to explore the composition changes due to the 
modified surface reactivity to antibody and lectins [72], [73]. Ivermectin disrupts Brugia 
malayi excretory-secretory apparatus function [74]. We could also detect whether it can 
disrupt C. elegans excretory-secretory system with proteomics. This work will allow future 
screening of small molecules that can interrupt excretome/secretome using our standard 
protocol as reference. These small molecules can be potential anthelmintic drugs.   
       This comparative proteomic method is limited by the detection power of Mass-Spec 
and the accuracy for quantitation. Using RNA-seq expression datasets would overcome this 
drawback of proteomics. We can benefit directly from the collection of hundreds of 
RNAseq expression datasets that are available in C. elegans without the efforts and money 
to repeat all conditions using Mass-Spec.  
        In summary, we established the standard profile of C. elegans ESPs and successfully 
identified 509 excreted/secreted proteins. Lysozymes, lectins, proteases, proteases 
inhibitors are the major protein groups in C. elegans excretome/secretome. C. elegans ESPs 
involve in many important pathways, including bacteria/pathogen defense, immune system 
regulation, nutrition uptake, and response to stimuli. Comparative proteomics allow quick 
selection of gene candidates for functional characterization. Lysozymes are up-regulated in 
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expression when exposing C. elegans to bacteria, consistent with their immuno-regulation 
roles.   
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2.5 Materials and Methods 
 
Excreted/Secreted Proteins Sample preparation 
        C. elegans wild type N2 strain was cultured in large quantities in liquid culture using 
E. coli HB101 as food source [75]. Initial concentration of 3 worms/µl was used to a 250 
ml S Medium system and worms were grown at 20°C for 7 days while shaking at 200 rpm. 
A drop of worm culture was examined under a compound microscope. Cultures with 
contaminating bacteria or fungal and cultures with large amounts of dead worms would be 
discarded. Mix-staged nematodes were then harvested by centrifuge and washed 
intensively six times in M9 buffer. Worms were left in 1 ml M9 buffer for incubation at 
20°C for another 4 hours. Supernatant was collected and filtered by a 0.22µm syringe filter 
unit and treated as the unconcentrated C. elegans Excreted/Secreted Proteins. 
 
nanoLC-MS/MS and data process 
        All excreted/secreted protein samples were digested by LysC and Trypsin enzymes 
after the reduction and alkylation of Cysteines.  In-solution digested C. elegans ESPs 
samples were chemically labeled using dimethyl labeling strategy. Briefly digested tryptic 
peptides are tagged on primary amines (N-terminus and amino group of lysine) using a 
mixture of cyanoborohydride and formaldehyde in their unlabeled and stable isotope-
labeled forms. In this study samples were labeled with regular formaldehyde and 
cyanoborohydride for the light label (+28) and deuterated formaldehyde and 
cyanoborohydride to generates a mass increase of +32 for the intermediate label. Then the 
samples were mixed desalted and subjected to LC-MS/MS analysis on a nanoflow LC 
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system, EASY-nLC II, (Thermo Fisher Scientific) coupled to a LTQ Orbitrap mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a Nanospray 
Flex ion source (Thermo Fisher Scientific). 
       For the EASY-nLC II system, solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% 
formic acid and solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. 
Samples were directly loaded onto a 16-cm analytical HPLC column (75 mm ID) packed 
in-house with ReproSil-Pur C18AQ 3 um resin (120A° pore size, Dr. Maisch, Ammerbuch, 
Germany). The column was heated to 45° C. The peptides were separated with a 120 min 
gradient at a flow rate of 350 nL/min. The gradient was as follows: 2–30% Solvent B (110 
min), 30–100% B (1 min), and 100% B (9 min). Eluted peptides were then ionized using a 
standard coated silica tip (New Objective, Woburn, MA) as an electrospray emitter and 
introduced into the mass spectrometer.  The LTQ Orbitrap was operated in a data-
dependent mode, automatically alternating between a full-scan (m/z 300-1700) in the 
Orbitrap and subsequent MS/MS scans of the 15 most abundant peaks in the linear ion trap 
(Top15 method). Data acquisition was controlled by Xcalibur 2.0.7 and Tune 2.4 software 
(Thermo Fisher Scientific). 
       Raw data was analyzed using MaxQuant (v. 1.5.3.30) [76], [77]. Spectra were searched 
against C. elegans entries in UniProt as well as a contaminant database containing common 
proteins like trypsin and keratins. Precursor mass tolerance was 4.5 ppm after recalibration 
and fragment tolerance was 0.5 Da. Carbamidomethylation of cysteine was specified as a 
fixed modification and protein N-terminal acetylation and oxidation of methionine were 
specified as variable modifications. Trypsin was the specified digestion enzyme and up to 
two missed cleavages were allowed. Score were thresholded so as to achieve a 1% FDR at 
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the PSM, peptide, and protein levels as estimated by a decoy database. Match-between-
runs, iBAQ, and LFQ quantitation were enabled. 
 
Bacteria strains 
       E. coli HB101, E. coli OP50, Bacillus subtilis, Bacillus mycoides were cultured in LB 
at 37°C. Bacillus simplex, Bacillus megaterium, Microbacterium nematophilum CBX102 
were obtained from Caenorhabditis Genetics Center (CGC) and cultured at 37°C. 
 
Stable isotope dimethyl labeling quantitative proteomics 
       After enzyme digestion of excreted/secreted protein samples, stable isotope dimethyl 
labeling protocol was followed as previously described to allow quantitative comparison 
for two samples [78]. The rest of the procedures were the same with regular nanoLC-
MS/MS.  
 
BLAST 
       Each protein sequence in the ESPs based on C. elegans genome release (WS 271) was 
blasted against NCBI using BLASTP search with the following parameters: BLAST 
expectation value (e-value) 1.0E-3, number of blast hits 20, HSP length cutoff 33[79] . 
 
Bioinformatics 
       Gene Ontology analysis was performed with Gene Ontology Consortium powered by 
PANTHER[43]–[45]. WormBase enrichment analysis tools were used to find enriched 
tissue, phenotype, and GO terms [80], [81]. The protein sequences were further searched 
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against Pfam search (version 32.0) with HMMER3 [54], SignalP (version 5.0) [29], 
InterProScan [53], KEGG [49]–[51], STRING [55], and MEROPS [56]for proteases and 
proteases inhibitors, dbCAN2 [57] for automated Carbonhydrate-active enzyme annotation. 
Blast2GO [82], [83]was used to add more GO and InterProScan results .  
 
BLAST map 
The C. elegans ESPs BLAST map was created similarly to [84]. All-to-all BLAST [85]was 
performed with the 509 C. elegans ESPs identified in this work, with a threshold of E-value 
< 0.1. The map was created using igraph package in R [86]. Edges between nodes 
(proteins) were plotted as percent identity scores, scaled between 0 and 1, in a force-
directed graph. Annotations for protein classes were pulled from WormBase [28] and 
Uniprot [87]. 
 
RNA interference 
       RNAi was performed by feeding nematodes dsRNA-producing bacteria using standard 
procedures with modifications to utse system [58]. PS6640 qyIs[Cdh-3 mk62-
63::membrane cherry]; unc-119(ed4); kuIs29[unc-119(+) + egl-13::GFP(pWH17)] was 
generated in Sternberg lab. Animals were scored at young adult or L4 lethargus stage. 
Image was taken with Zeiss LSM 710 Inverted confocal microscope with a ×100 Plan-
APOCHROMAT objective and ZEN acquisition software.  
 
RT-qPCR 
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      Quantitative PCR was performed as previously described using pmp-3 as a reference 
gene [88]. C. elegans wilde type N2 worms were cultured on E. coli OP50, Bacillus subtilis 
and Bacillus mycoides lawn for 6 days. Worms were washed off plates with M9 and 
washed for another 5 times. The concentrations of worms were counted under compound 
microscope. Equal numbers of worms were used to RNA extraction steps. RNAs were 
prepared by Trizol extraction and purified by RNAeasy kit. Reverse transcription was 
carried out using SuperScript III First-Strand Synthesis System for RT-PCR from 
Invitrogen. 8 µL of RNA was mixed with 1 µL of (dT)20 and 1 µL of 10mM dNTP and the 
mixture was incubated at 65°C for 5 min then left on ice for 10 min. 2 µL of 10X RT 
buffer, 4 µL of 25mM MgCl2, 2 µL of 0.1M DTT, 1 µL of RNaseOUT and 1 µL of 
SuperScript III RT was added to 10 µL of mixture from the first step. The new mixture was 
incubated at 50°C for 50 min, followed by 85°C for 5 min. 1 µL of RNase H was added to 
the system and new mixture was incubated for 20 min at 37°C. qPCR was performed using 
the Roche LightCycler 480 SYBR Green I Master in the LightCycler 480 System. The 
cDNA was diluted by12.5 fold. 5 µL of diluted cDNA was mixed with 3 µL of PCR grade 
water, 2 µL of 5 µM primers, 10 µL of 2X master mix. Each qPCR reaction was performed 
with three technical replicates and three biological replicates. Crossing point-PCR-cycle 
(Cp) averages were computed for each group of three technical replicates; these values 
were then subtracted from the respective average Cp value of the reference gene. 
Primers used in RT-qPCR: 
pmp-3 
5’-primer: GTTCCCGTGTTCATCACTCAT 
3’-primer: ACACCGTCGAGAAGCTGTAGA 
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ilys-2 
5’-primer: CTATTGCGGTCGCCTACGC  
3’-primer: GAACATCCGCAGCAGCTGTG   
ilys-3 
5’-primer: GACTATTGCGGTCGCCTACG  
3’-primer: GCACAGCTAAGATCATTCGCG  
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2.6 Figures  
  
 
Figure 2.1 Workflow of proteomics characterization of C. elegans ESPs. large 
quantities of C. elegans were collected and incubated in buffer, followed by enzyme 
digestion and LC-MS/MS and then MaxQuant processing to identify peptides. 
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Figure 2.2 Venn diagram showing overlap of identified C. elegans ESPs from four 
biological replicates of nano LC-MS/MS. Four biological replicates were labeled with A, 
B, C, and D and numbers represent the count of proteins.  
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Figure 2.3 Tissue enrichment Analysis of C. elegans ESPs. Tissue enrichment analysis 
tool from WormBase was used to find out over-represented anatomical tissues.  
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Figure 2.4 Gene Ontology enrichment analysis result on cellular component 
Enrichment analysis was used with a cut-off of FDR p<0.05. GO terms were ranked by –
log (FDR). FDR, false discovery rate.  
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Figure 2.5 Gene Ontology enrichment analysis result on biological process. 
Enrichment analysis was used with a cut-off of FDR p<0.05. GO terms were ranked by –
log (FDR). FDR, false discovery rate.  
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Figure 2.6 Gene Ontology enrichment analysis result on molecular function. 
Enrichment analysis was used with a cut-off of FDR p<0.05. GO terms were ranked by –
log (FDR). FDR, false discovery rate.  
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Figure 2.7 Top 20 enriched KEGG pathways in C. elegans ESPs. Enrichment analysis 
was used with a cut-off of FDR p<0.05. Pathways were ranked by –log (FDR). FDR, false 
discovery rate. 
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Figure 2.8 Top 20 enriched reactome pathways in C. elegans ESPs. enrichment analysis 
was used with a cut-off of FDR p<0.05. Pathways were ranked by –log (FDR). FDR, false 
discovery rate. 
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Figure 2.9 Top 30 enriched protein domain structures after searching against 
InterPro enrichment analysis was used with a cut-off of FDR p<0.05. Pathways were 
ranked by –log (FDR). FDR, false discovery rate. 
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Figure 2.10 Top 15 enriched protein domain structures after searching against Pfam 
enrichment analysis was used with a cut-off of FDR p<0.05. Pathways were ranked by –log 
(FDR). FDR, false discovery rate. 
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Figure 2.11 BLAST map of C. elegans ESPs. Edges indicate similarity by BLAST, with 
an E-value < 0.1. Color-coded are the ten protein classes with the highest numbers among 
the ESPs.  
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Figure. BLAST map of C. elegans ESPs. Edges indicate similarity by BLAST, with an E-value < 0.1. Color 
coded are the ten protein classes with the highest number of members among the ESPs. 
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Figure 2.12 Protein-Protein interaction network of C. elegans ESPs visualized by 
STRING. Color saturation of the edges represents the confidence score of a functional 
association. The section in the middle was enlarged to the right, showing several proteins 
from Cathepsin Z family and Cathepsin B family, which are at the core position to interact 
with other proteins.  
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Figure 2.13 Defective in utse arm outgrowth and nuclei localization when using RNAi 
to knockdown expression of proteases and proteases inhibitors. (A) Left: the nuclei 
localization in wild type (N2) L4 lethargus worms. Right: utse cell body marked by cdh-
3::mcherry. (B) Knocking down expression of nas-22 gene by RNAi. Left: dotted circles 
indicated the nuclei postion in wild type. Right: disrupted cell body of utse. (C) Knocking 
down expression of cpi-1 gene by RNAi. Left: nuclei migration was disrupted in utse. 
Right: cell outgrowth looked similar to wild type. (D) Knocking down expression of cpr-1 
gene by RNAi. Left: nuclei migration was disrupted in utse. Right: disrupted cell body of 
utse. Panel A and B are modified from [58]. 
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Figure 2.14 Intensity scatter plot of C. elegans ESPs from nematodes cultured at 20°C 
over C. elegans ESPs from nematodes cultured at 15°C. Each dot represented one 
excreted/secreted protein.  
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Figure 2.15 Intensity scatter plot of C. elegans ESPs from nematodes cultured at 25°C 
over C. elegans ESPs from nematodes cultured at 20°C. Each dot represented one 
excreted/secreted protein. 
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Figure 2.16 Phenotype enrichment Analysis of C. elegans ESPs. Phenotype enrichment 
analysis tool from WormBase was used to find out over-represented gene associated 
phenotypes.  
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Figure 2.17 Intensity scatter plot of C. elegans ESPs from nematodes cultured with E. 
coli OP50 diet over ESPs with E. coli HB101 diet. Each dot represented one 
excreted/secreted protein. 
 
 
 
 
 
 69 
 
 
Figure 2.18 qRT-PCR results showed expression level of ilys-2 and ilys-3 were 
increased when challenging C. elegans with Bacillus subtilis and Bacillus mycoides. 
OP50, E. coli OP50.  
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Figure 2.19 GO enrichment Analysis of C. elegans ESPs. GO enrichment analysis tool 
from WormBase was used to find over-represented anatomical GO terms.  
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2.7 Tables 
 
Table 2.1 Identified C. elegans ESPs with reported evidence of secretion from 
Uniprot. Only 25 identified ESP from C. elegans were reported to be secreted proteins. 
 
 
 
 
 
 
Protein(ID( Gene(names( Protein(names(
O01530& asp*6& Aspar.c&protease&6&
O62053& C08F11.11& UPF0375&protein&C08F11.11&
O45944& Y45F10C.4& UPF0375&protein&Y45F10C.4&
P34383& far*2& FaAy*acid&and&re.nol*binding&protein&2&
O76840*3& mig*6& Papilin&
Q21059& hch*1& Zinc&metalloproteinase&nas*34&
Q9XWV2& Y37D8A.2& Puta.ve&phospholipase&B*like&1&
P55956& asp*3& Aspar.c&protease&3&
Q9U3R0& C08F11.12& UPF0375&protein&C08F11.12&
Q9XWC2& Y73F4A.1& DOMON&domain*containing&protein&Y73F4A.1&
Q9U256& Y52B11A.8& Phospholipase&A2*like&protein&Y52B11A.8&
P18947& vit*4& Vitellogenin*4&
Q18594& C44B7.5& Uncharacterized&protein&C44B7.5&
O17861& F37H8.5& GILT*like&protein&F37H8.5&
O62146& F09B12.3& Puta.ve&phospholipase&B*like&2&
H9G352& unc*52& Basement&membrane&proteoglycan&
P55955& Ar*16& Transthyre.n*like&protein&16&
Q22285& Ar*46& Transthyre.n*like&protein&46&
Q22396& nas*20& Zinc&metalloproteinase&nas*20&
Q9BL07& Y54F10AM.8& Puta.ve&phospholipase&B*like&3&
O77469*3& \l*1C& Fibulin*1&
Q7JLI1*2& nas*31& Zinc&metalloproteinase&nas*31&
G8JY38& vit*2& Vitellogenin*2&
P34714& ost*1& SPARC&
Q03610& ZC84.1& Uncharacterized&protein&ZC84.1&
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Table 2.2 Top 25 most abundant proteins identified in C. elegans 
excretome/secretome. Several protein families, including aspartic and serine proteases, 
lysozymes, nematode specific peptide family, and saposin-like protein family, were the 
most abundant proteins in C. elegans ESPs. 
 
 
 
 
 
 
 
 
 
WormBase ID Protein names Gene names Short annotation 
WBGene00000219 Aspartic protease 6 asp-6 Aspartic protease 6 
WBGene00017691 ilys-5 Invertebrate LYSozyme;Invertebrate LYSozyme 
WBGene00000214 asp-1 ASpartyl Protease 
WBGene00008358 nspc-18 Nematode Specific Peptide family, group C 
WBGene00000535 cpi-1 Cystatin 
WBGene00004990 spp-5 SaPosin-like Protein family 
WBGene00016781 Uncharacterized protein 
WBGene00015392 nspc-10 Nematode Specific Peptide family, group C 
WBGene00000784 Cathepsin B-like cysteine proteinase 4 cpr-4 Cathepsin B-like cysteine proteinase 4 
WBGene00009639 nspc-15 Nematode Specific Peptide family, group C 
WBGene00004999 spp-14 SaPosin-like Protein family 
WBGene00008572 Uncharacterized protein F08B12.4 F08B12.4 Uncharacterized protein F08B12.4 
WBGene00007458 UPF0375 protein C08F11.11 C08F11.11 UPF0375 protein C08F11.11 
WBGene00010204 Uncharacterized protein 
WBGene00013867 Uncharacterized protein 
WBGene00000218 asp-5 ASpartyl Protease 
WBGene00008841 Uncharacterized protein 
WBGene00004987 spp-2 SaPosin-like Protein family 
WBGene00017127 Uncharacterized protein 
WBGene00017881 asp-13 ASpartyl Protease 
WBGene00016670 ilys-3 Invertebrate LYSozyme 
WBGene00009895 scl-2 SCP-Like extracellular protein 
WBGene00019682 Putative serine protease K12H4.7 K12H4.7 Putative serine protease K12H4.7 
WBGene00000216 Aspartic protease 3 asp-3 Aspartic protease 3 
WBGene00003096 lys-7 LYSozyme 
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Table 2.3 Over or under represented Cellular Component GO terms. Fisher’s exact 
test was used in enrichment analysis. Results were shown with p<0.05. 
 
 
GO#cellular#component#complete#
Caenorhabdi4s#elegans#
7#REFLIST#(19921)# Ce_ESP(508)#
Ce_ESP#
(expected)#
Ce_ESP#(over/
under)#
Ce_ESP#(fold#
Enrichment)#
Ce_ESP(raw#P7
value)#
Ce_ESP#
(FDR)#
vesicle'lumen'(GO:0031983)' 3' 3' 0.08' +' 39.21' 2.89E904' 9.18E903'
proteasome'core'complex,'alpha9subunit'complex'(GO:0019773)' 7' 6' 0.18' +' 33.61' 3.40E907' 2.56E905'
proteasome'core'complex'(GO:0005839)' 14' 8' 0.36' +' 22.41' 3.26E908' 2.62E906'
membrane'microdomain'(GO:0098857)' 47' 24' 1.2' +' 20.02' 3.27E921' 6.59E919'
membrane'region'(GO:0098589)' 47' 24' 1.2' +' 20.02' 3.27E921' 5.64E919'
membrane'raI'(GO:0045121)' 47' 24' 1.2' +' 20.02' 3.27E921' 4.94E919'
proton9transporJng'V9type'ATPase,'V1'domain'(GO:0033180)' 8' 4' 0.2' +' 19.61' 1.60E904' 6.02E903'
proton9transporJng'two9sector'ATPase'complex,'catalyJc'domain'(GO:
0033178)' 15' 7' 0.38' +' 18.3' 6.96E907' 4.67E905'
proton9transporJng'V9type'ATPase'complex'(GO:0033176)' 19' 5' 0.48' +' 10.32' 2.68E904' 8.74E903'
lysosome'(GO:0005764)' 99' 22' 2.52' +' 8.71' 2.54E913' 2.55E911'
lyJc'vacuole'(GO:0000323)' 100' 22' 2.55' +' 8.63' 3.03E913' 2.81E911'
proton9transporJng'two9sector'ATPase'complex'(GO:0016469)' 38' 8' 0.97' +' 8.26' 1.57E905' 9.49E904'
proteasome'complex'(GO:0000502)' 42' 8' 1.07' +' 7.47' 2.97E905' 1.70E903'
vacuole'(GO:0005773)' 150' 28' 3.83' +' 7.32' 6.47E915' 7.10E913'
endopepJdase'complex'(GO:1905369)' 44' 8' 1.12' +' 7.13' 3.98E905' 2.09E903'
collagen9containing'extracellular'matrix'(GO:0062023)' 46' 7' 1.17' +' 5.97' 3.23E904' 9.75E903'
extracellular'region'(GO:0005576)' 575' 83' 14.66' +' 5.66' 3.31E935' 1.33E932'
pepJdase'complex'(GO:1905368)' 56' 8' 1.43' +' 5.6' 1.80E904' 6.60E903'
extracellular'region'part'(GO:0044421)' 345' 48' 8.8' +' 5.46' 6.06E920' 8.13E918'
extracellular'space'(GO:0005615)' 306' 41' 7.8' +' 5.25' 1.14E916' 1.38E914'
extracellular'matrix'(GO:0031012)' 95' 11' 2.42' +' 4.54' 6.68E905' 2.88E903'
myoﬁbril'(GO:0030016)' 97' 11' 2.47' +' 4.45' 7.92E905' 3.30E903'
whole'membrane'(GO:0098805)' 274' 29' 6.99' +' 4.15' 6.36E910' 5.48E908'
sarcomere'(GO:0030017)' 89' 9' 2.27' +' 3.97' 7.51E904' 2.11E902'
contracJle'ﬁber'(GO:0043292)' 160' 13' 4.08' +' 3.19' 4.04E904' 1.19E902'
supramolecular'ﬁber'(GO:0099512)' 304' 20' 7.75' +' 2.58' 1.93E904' 6.84E903'
supramolecular'polymer'(GO:0099081)' 306' 20' 7.8' +' 2.56' 2.09E904' 7.21E903'
supramolecular'complex'(GO:0099080)' 311' 20' 7.93' +' 2.52' 2.55E904' 8.55E903'
cytoplasmic'part'(GO:0044444)' 2572' 92' 65.59' +' 1.4' 1.04E903' 2.84E902'
Unclassiﬁed'(UNCLASSIFIED)' 8437' 262' 215.15' +' 1.22' 4.15E905' 2.09E903'
cellular_component'(GO:0005575)' 11484' 246' 292.85' 9' 0.84' 4.15E905' 2.00E903'
nucleus'(GO:0005634)' 2472' 28' 63.04' 9' 0.44' 4.46E907' 3.16E905'
plasma'membrane'(GO:0005886)' 1350' 14' 34.43' 9' 0.41' 9.68E905' 3.77E903'
membrane'(GO:0016020)' 6685' 65' 170.47' 9' 0.38' 4.00E926' 9.65E924'
membrane'part'(GO:0044425)' 6315' 57' 161.04' 9' 0.35' 1.07E926' 3.24E924'
nuclear'part'(GO:0044428)' 866' 6' 22.08' 9' 0.27' 8.55E905' 3.44E903'
nuclear'lumen'(GO:0031981)' 580' 4' 14.79' 9' 0.27' 1.75E903' 4.70E902'
plasma'membrane'part'(GO:0044459)' 897' 5' 22.87' 9' 0.22' 1.44E905' 9.15E904'
integral'component'of'membrane'(GO:0016021)' 5897' 29' 150.38' 9' 0.19' 7.52E941' 9.07E938'
intrinsic'component'of'membrane'(GO:0031224)' 5905' 29' 150.58' 9' 0.19' 7.63E941' 4.60E938'
integral'component'of'plasma'membrane'(GO:0005887)' 602' 2' 15.35' 9' 0.13' 5.05E905' 2.34E903'
intrinsic'component'of'plasma'membrane'(GO:0031226)' 607' 2' 15.48' 9' 0.13' 5.15E905' 2.30E903'
neuron'projecJon'(GO:0043005)' 424' 1' 10.81' 9' 0.09' 4.21E904' 1.21E902'
neuron'part'(GO:0097458)' 535' 1' 13.64' 9' 0.07' 3.06E905' 1.68E903'
transferase'complex'(GO:1990234)' 345' 0' 8.8' 9' '<'0.01' 3.20E904' 9.89E903'
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Table 2.4 Over or under represented Biological Process GO terms. Fisher’s exact test 
was used in enrichment analysis. Results are shown with p<0.05. 
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Table 2.5 Over or under represented Molecular Function GO terms. Fisher’s exact test 
was used in enrichment analysis. Results are shown with p<0.05. 
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Table 2.6 Predicted Carbohydrate-active enzymes (CAZyme) in C. elegans ESPs. GH, 
Glycoside Hydrolase. CBM, Carbohydrate-Binding Module. GT, GlycosylTransferase.  
 
 
 
 
 
 
Gene_ID HMMER Hotpep DIAMOND Signalp #ofTools 
sp|O16580|GLCM1_CAEEL GH30_1(86-517) N GH30_1 Y(1-24) 2 
sp|Q11174|CHIT_CAEEL GH18(57-403) GH18 CBM14 N 3 
sp|Q20967|LYS5_CAEEL GH25(22-202) N GH25 Y(1-18) 2 
sp|Q22492|HEXA_CAEEL GH20(166-504) GH20 GH20 N 3 
sp|Q9UB00|GLCM4_CAEEL GH30_1(84-518) GH30 GH30_1 N 3 
tr|O76632|O76632_CAEEL GH35(35-353) GH35 GH35 N 3 
tr|P91982|P91982_CAEEL GH13_15(57-355) GH13 GH13_15 N 3 
tr|Q17816|Q17816_CAEEL GH19(60-361) GH19 GH19 Y(1-24) 3 
tr|Q19004|Q19004_CAEEL GH31(281-783) GH31 GH31 Y(1-25) 3 
tr|Q19874|Q19874_CAEEL GH152(26-233) N GH152 Y(1-20) 2 
tr|Q19876|Q19876_CAEEL GH152(26-233) N GH152 Y(1-20) 2 
tr|Q20964|Q20964_CAEEL GH25(32-200) N N Y(1-17) 1 
tr|Q20968|Q20968_CAEEL GH25(32-199) N GH25 N 2 
tr|Q21750|Q21750_CAEEL GH31(268-779) GH31 GH31 Y(1-19) 3 
tr|Q21801|Q21801_CAEEL GH27(122-310) GH27 GH27 N 3 
tr|Q27526|Q27526_CAEEL GH35(51-369) GH35 GH35 N 3 
tr|Q95Q32|Q95Q32_CAEEL GH2(25-609) GH2 GH2 N 3 
tr|O76358|O76358_CAEEL N GH22 N Y(1-19) 1 
tr|A0A0K3AYJ1|A0A0K3AYJ1_CAEEL N GH22 N N 1 
tr|O76357|O76357_CAEEL N GH22 N Y(1-19) 1 
tr|O45599|O45599_CAEEL N CBM14 CBM14 Y(1-28) 2 
sp|P41996|CPG2_CAEEL N CBM14 CBM14 Y(1-19) 2 
sp|Q17802|CPG1_CAEEL N CBM14 CBM14 Y(1-18) 2 
tr|Q18529|Q18529_CAEEL N CBM14 CBM14 N 2 
tr|Q09975|Q09975_CAEEL N N GH25 Y(1-24) 1 
sp|O16202|LYS7_CAEEL N N GH25 Y(1-20) 1 
tr|O01780|O01780_CAEEL N N CBM14 Y(1-19) 1 
sp|O62415|LYS1_CAEEL N N GH25 N 1 
sp|O62416|LYS2_CAEEL N N GH25 Y(1-20) 1 
sp|Q9XXK1|ATPA_CAEEL N N GT4 N 1 
tr|Q21650|Q21650_CAEEL N N CBM14 Y(1-22) 1 
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Table 2.7 List of screened proteases and proteases inhibitors using RNAi. The 
deficiency rate of utse development is recorded.  
 
 
 
RNAi%targe+ng%genes% Defec+ve%rate(%)% P6value%
cpz$1& 0.1$ 0.2747$
Y52B11A.8& 0$ 0.7553$
clec$15& 0.5$ 0.0001$
F37H8.5& 0$ 0.7553$
unc$52& 0.1$ 0.2747$
far$2& 0$ 0.7553$
Y37D8A.2& 0$ 0.7553$
ilys$3& 0.2$ 0.0567$
cpi$1& 0.3$ 0.0084$
=r$16& 0.6$ 0.0000$
=r$17& 0.4$ 0.001$
cpl$1& 0.1$ 0.2747$
mlt$11& 0.2$ 0.0567$
cpi$2& 0.3$ 0.0084$
asp$6& 0.2$ 0.0567$
mig$6& 0.6$ 0.0000$
nas$31& 0$ 0.8663$
nas$20& 0.1$ 0.2747$
cpr$1& 0.1$ 0.2747$
cpr$6& 0$ 0.7553$
vit$1& 0.2$ 0.0567$
tbh$1& 0.1$ 0.2747$
Y52B11A.8& 0.1$ 0.2747$
far$2& 0$ 0.7553$
F37H8.5& 0$ 0.7163$
F41C3.5& 0$ 0.7553$
hsp$3& 0.2$ 0.0567$
asp$6& 0.3$ 0.0084$
=r$17& 0.2$ 0.0567$
cpi$1& 0.2$ 0.0567$
=r$16& 0$ 0.7973$
ilys$3& 0.1$ 0.2747$
cpr$1& 0.25$ 0.1371$
cpr$6& 0$ 0.7553$
ost$1& 0.1$ 0.2747$
unc$52& 0.2$ 0.0567$
Y37D8A.2& 0$ 0.7553$
nas$31& 0.1$ 0.2747$
mig$6& 0.8$ 0.0000$
vit$1& 0.1$ 0.2747$
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Table 2.8 Up-regulated genes in C. elegans ESPs when culturing nematodes on 
Bacillus subtilis and Bacillus mycoides diet.  
 
 
 
  
B.#sub'lis/OP50& Fold&change& B.#mycoides/OP50& Fold&change&
ilys%2' 288# ilys%2' 1155#
ilys%3' 74# ilys%3' 183#
)r%15' 7.8# Pud%2.1' 22.11#
clec%50' 6.7# Pud%1.2' 5.9#
Pud%2.1'(protein'upregulated'in'daf%2)' 6.6# )r%15' 4.6#
cpr%5' 6# cpr%1' 4.1#
K12H4.7'(putaAve'serine'protease)' 5.2#
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C h a p t e r  3  
IDENTIFICATION OF STAGE SPECIFIC AND PATHOGEN 
RESPONSE SPECIFIC EXCRETED/SECRETED 
PROTEINS OF CAENORHABDITIS ELEGANS BY 
COMPARATIVE ANALYSIS OF DIFFERENTIAL GENE 
EXPRESSION   
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3.1 Abstract 
 
The compositions of C. elegans excretome/secretome is dynamic through 
developmental life stages and in response to environmental changes. We took 
advantage of the deeply sequenced transcriptome of C. elegans under many 
conditions including stages and upon pathogen infections to identify stage-specific 
and pathogen-associated ESP encoding genes. By this simple comparative method, 
we successfully characterized L1, L3, adult, L2 dauer and post dauer related ESPs. 
We demonstrated that expressions of proteases inhibitors are up-regulated during 
dauer formation while proteases expressions are increased during dauer exit. We 
performed nano LC-MS/MS to directly characterize excreted/secreted proteins 
with dauer cultures. The comparison between proteomics and RNAseq dauer 
expression profiles revealed 91 ESP encoding genes that are highly expressed in 
dauers. We performed dauer formation assay to these dauer-associated gene 
mutants. The excellent prediction rate confirmed that our comparative method is 
the simplest way to identify candidates for functional assays. Similarly, we 
employed this comparative method to pathogen-induced transcriptomes. We 
reported a group of genes that are associated with Serratia marcescens infection 
and a group of bacterial/pathogen responding genes. We confirmed the roles of C. 
elegans ESPs in immunoregulation by infection assays with various pathogens. 
Lysosomes and cysteine protease inhibitor are among the most important genes in 
the innate immune response pathway of C. elegans defending pathogen infection.  
 93 
3.2 Introduction 
 
        We reported the standard protocol to characterize protein components of C. 
elegans excretome/secretome using mixed staged worms cultured at 20 °C with E. 
coli HB101 as diet. However, the composition of ESPs is dynamic and is under 
accurate transcriptional and translational regulation [1]. ESPs function directly at 
the interfaces between free-living nematodes/parasites and environment/host [2]–
[5]. They need to quickly respond to the environmental stimuli to maintain C. 
elegans homeostasis [6]. 
        The dynamics in ESPs composition can be studied by comparing ESPs of 
different developmental stages and under different conditions.  The model 
organism Encyclopedia of DNA Elements (modENCODE) project on C. elegans 
allowed in depth systematical annotation of functional genomic elements [7]. Up 
to now, 669 C. elegans datasets have been deposited. Transcriptome profiles of C. 
elegans from a variety of developmental stages, conditions and tissues would 
provide a solid foundation for comparative functional studies [8], [9]–[14]. 
        C. elegans, as a free-living nematode, undergoes four larval stages after hatch 
and reach reproductive stage in about 3 days under favorable condition [15]. Under 
unfavorable conditions, C. elegans would enter an alternative development cycle, 
forming non-aging dauer larvae that can survive for months [16]. In parasites, each 
species has its distinct life cycle. Parasites life cycles involve the invasion and 
exploitation of more than one host [17]. Each life cycle stage of parasites has both 
common and unique features [4], [18]. Despite the complexity in a parasites’ life 
 94 
cycles, nematodes typically undergo four larval molts, suggesting C. elegans can 
serve as the reference model to study environment regulated developmental 
changes [2], [17], [19].   
        Dauer is of particular interest because the well-accepted hypothesis that 
parasite infective larvae has evolved from free-living nematode dauer [20]–[22]. 
Dauer share a lot of common features with parasite infective larvae, including slim 
bodies, constricted esophagus, closed mouth [16], [20], [22], [23]. Dafachronic 
acid (DA) is required in both dauer and parasites for dauer/infective larvae 
formation [24]–[27]. This shared mechanism strongly supports that parasitism may 
be acquired from dauer to infective larvae evolution.  
        Thus, we took advantage of the deeply sequenced C. elegans transcriptomes 
though all developmental stages and extracted the expression profiles of C. 
elegans ESPs [7]. We performed clustering to identify co-expressed genes 
associated with different stages [28], [29]. These stage-specific ESPs would 
provide insights towards the mechanisms of nematodes life stage transition. We 
were able to characterize several groups of genes related with L3, adult, L2d dauer, 
and post dauer. Interestingly, L2d dauer has up-regulated expression of many 
proteases inhibitors and post dauer has up-regulated expression of many proteases. 
This indicates the formation and exit of dauer developmental stage is under 
accurate regulation of enzyme activates. 
        C. elegans encounters a wide variety of bacteria and fungi in nature [30]. 
Among these, several bacteria and fungi have been proved to be pathogenic to C. 
elegans, causing shortened life span or non-lethal disease [31]–[34]. These 
 95 
infection models have been studied intensively to study the host-pathogen 
interaction and to identify host pathways exploited by pathogens. C. elegans ESPs 
are the major players in immunoregulation. RNAi experiments targeting several 
ESPs including lys-1, lys-8, cpi-1, cpi-2, spp-5, and asp-3 showed increased 
pathogen susceptibility or altered life span, supporting the hypothesis that one 
major role of C. elegans ESPs is to defend against pathogen infection [35]–[38].  
         Therefore, we examined the expressional regulation of C. elegans ESPs with 
transcriptome data upon bacterial or fungal infections [8]. The C. elegans ESPs fall 
into five common expression groups. We were able to identify a group of genes 
that is more up-regulated in Serratia marcescens infection and a group of genes 
that is more “bacterial pathogen responding” rather than “fungal pathogen 
responding”. Among these genes, lysozymes are also among the most abundant 
ESPs. We further confirmed their functions in innate immune response by 
infecting C. elegans with Serratia marcescens, Pseudomonas aeruginosa PA14 
and Microbacterium nematophilum.  
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3.3 Results 
 
ESP-encoding genes can be assigned into seven groups by clustering based on 
expression similarity through developmental stages  
       We utilized the RNA-seq expression profiles associated with different C. 
elegans developmental stages from Gerstein et al [7]. Using the 
excretome/secretome profile of mix-staged C. elegans, we pooled the expression 
profiles of these ESP-encoding genes from the 244 expression experiments 
reported in the paper. We combined and collapsed the experiments results from the 
same developmental stage. Thus, data were assigned to 10 developmental stage 
categories (embryo, L1-stage larvae, L2-stage larvae, L3-stage larvae, L4-stage 
larvae, young adult, adult, L2d dauer, dauer, and post-dauer). The median value of 
TPM (Transcipts Per Kilobase Million) was taken in each stage categories. Soft 
clustering was performed to cluster genes with common expression profiles 
(Figure 3.1) [28], [29].  
        The genes encoding C. elegans excreted/secreted proteins can be sorted into 7 
clusters (Appendix table 3.1). We examined the enriched Gene Ontology (GO) 
terms and enriched biochemical pathways with KEGG biochemical pathway data 
[39]–[45].  
         55 Genes were assigned into cluster 1 and they have higher expressions in 
L1-stage animals. They are enriched in “Glycolysis/Gluconeogenesis” and 
“Phagosome” KEGG pathways.  
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         In cluster 2, 86 genes have a relatively higher expression in L3 larva stage 
than the others. The enriched KEGG pathway include “Lysosome” and 
“Autophagy-animal”, as may be expected for their immune regulation roles. This 
cluster of genes contains enriched group of aspartic peptidase, cysteine-type 
endopeptidase, lysozyme, and hydrolase, indicating that this cluster of genes is 
enzymatically active. Enriched biological process GO terms include “innate 
immune response”, “defense response to bacterium”, “response to stress”, 
“peptidoglycan metabolic process”, “cell wall metabolic process”, and “response 
to external stimulus”. This is consistent with our finding that one major role of 
excreted/secreted proteins is to regulate innate immune response to 
bacteria/pathogen/environmental changes. Enriched cellular component GO terms 
include “lysosome”, “vacuole”, and “extracellular region”, as may be expected due 
to the secreted nature of the proteins.  
         Cluster 3 contains 74 genes. These genes are expressed more in the late 
developmental stage like adult stage. The enriched GO terms include “chitin 
binding”, “eggshell formation”, “oogenesis”. In fact, several proteoglycan proteins 
including cpg-1 and cpg-3 were included in this cluster. cpg-1 is involved in 
eggshell formation and is expressed in eggshell and germ line [46]. This is 
consistent with the active reproduction process in adult hermaphrodite. GO terms 
of “nutrient reservoir activity”, and “defense response to Gram-positive 
bacterium” are also enriched. This is consistent with the hypothesis that 
excreted/secreted proteins are important players in helping nutrition uptake and 
food processing [5], [6].  
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        Cluster 4 genes are more like post-dauer related (74 genes). Thus, this group 
of gene may function as the key players at the dauer to developmental stage 
transition. “Lysosome” is the enriched KEGG pathway in this cluster.  This cluster 
contains genes from several protein families, including cysteine peptidase, 
threonine peptidase, and zinc metalloproteinase.  
        In cluster 5, 72 genes are highly expressed in L2d dauer.  Studying this cluster 
of genes may provide clues for decision making in early dauer.  The biological 
process GO terms enriched in this group are “negative regulation of endopeptidase 
activity”, “negative regulation of proteolysis”, and “negative regulation of 
hydrolase activity”. This cluster contains a lot of proteases inhibitors, in contrast to 
the enriched proteases during dauer exit in cluster 4. This contrast is of particular 
interest, suggesting the enzyme active levels are down-regulated during dauer and 
would be turned up again during dauer exit.  
        Cluster 6 has fewer genes (only 18 genes) than other clusters and the genes in 
this group are slightly expressed more in embryo but in general the expressions are 
relatively stable across development stages. 
        Cluster 7 contains 125 genes with clearly higher expression in L3 larva stage. 
The enriched KEGG pathways are “Lysosome” and “Biosynthesis of amino 
acids”. The enriched biological process GO terms include “innate immune 
response”, “proteolysis”, “response to stress”, and “catabolic process”. Cluster 7 
shares a lot in common with cluster 2, which also has higher expression level in 
L3. But they differ in the type of active enzymes. Cluster 7 contains more serine-
type exopeptidases and serine-type hydrolase.  
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         In short, we identified stage-specific ESPs based on their expression profiles. 
Studying stage-specific ESPs would provide information to characterize ESPs 
function related with unique biological features in each developmental stage. This 
could also be used to compare with stage-specific ESPs from parasites, which 
comprise more distinct and complicated life styles [2]–[4].  
 
Direct profiling of dauer excreted/secreted proteins with proteomics 
         To validate the clustering method, we wanted to directly characterize the 
composition of stage-specific excretome/secretome. We found dauer is of 
particular interest since dauer is believed to be equivalent to infective larvae in 
parasites in development stages. The similarities between dauer and infective 
larvae lead to the hypothesis that dauer is a pre-adaptation for parasitism [20], [22]. 
Parasitism is closely related to series of discrete immune responses [47]. Thus, 
identification of dauer-specific ESPs would help to find key functional regulators 
in the innate immune response pathways.  
         To investigate the composition of dauer excretome/secretome, we employed 
similar proteomic method as previously reported. C. elegans dauers were obtained 
in liquid culture by adding dauer-inducing pheromone [48]. The dauer 
excreted/secreted proteins were collected after incubation and were subjected to 
nanoLC-MS/MS. A total of 430 proteins were identified through Mass-Spec in 
dauer excretome/secretome.  
 
Validation of dauer ESPs with dauer RNA-seq expression result 
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       Previous works in this lab had established a sophisticated design to pinpoint 
key time points during dauer formation and dauer exit. Briefly, daf-9 (dh6) null 
mutant with deficiency to produce growth hormone dafachronic acid (DA) was 
used. This strain is dauer-constitutive if not introducing synthetic DA to the 
culture. The RNA samples of daf-9 (dh6) mutant were taken at the following 
timepoints: with no DA, “L2d” at 24 hours post hatch (hph), “L2d” at 26 hph, 
“dauer-committed L2d” at 34 hph, “fully developed dauers” at 60 hph; with DA 
added at 24 hph, “L3-committing larvae” at 26 hph, “L4” at 34 hph [49].  
         We extracted the expression profiles of dauer ESPs from the transcription 
data (Figure 3.3) [49]. In summary, 91 ESP-encoding genes were highly 
expressed in “dauer-committed L2d” and “fully developed dauers” experiments. 
We considered this subset of ESPs to be dauer-specific.  This group of genes is 
enriched in “Longevity regulating pathway” and “Phagosome” pathway. This is 
consistent with the extended life span of dauers. The enriched molecular function 
GO terms are “endopeptidase inhibitor activity”, “endopeptidase regulator 
activity”, “peptidase inhibitor activity”, and “peptidase regulator activity”, 
suggesting the proteases inhibitors are up-regulated in expression during dauer 
stage. This is consistent with the observation in Cluster 5 in last section.  
 
Screen of candidate genes for deficiency in dauer entry  
        To investigate the function of dauer-specific ESPs, we performed a screen for 
dauer entry deficiency on available mutants. We first narrowed down the list by 
picking out genes with some level of annotation related to secretion. Then we 
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chose genes with available knockout strains in CAENORHABDITIS GENETICS 
CENTER (CGC). A total of 13 genes were screened for dauer entry phenotype. 
Among these, 10 strains showed a decreased dauer formation (Figure 3.4). Our 
result suggested we successfully predict dauer-specific ESPs. Among these, cpi-1 
and cpi-2, two cysteine protease inhibitors, promote dauer formation.  
 
Clustering revealed pathogen-associated ESP encoding genes 
         C. elegans responds to distinct pathogens by regulating the expression of 
specific subset of genes [12], [13], [33], [50], [51]. Transcriptional profiles of C. 
elegans in response to infection by three bacterial (Serratia marcescens, 
Enterococcus faecalis and otorhabdus luminescens) and two fungal pathogens 
(Drechmeria coniospora and Harposporium sp.) were taken for comparative 
studies [8].  
         We extracted the expression of C. elegans ESPs from the 5 transcriptional 
profiles mentioned above. Similar clustering method was conducted to identify co-
expressing genes (Figure 3.5).  
         The genes encoding C. elegans excreted/secreted proteins were sorted into 5 
clusters (Appendix table 3.2). Similarly, GO term and KEGG biochemical 
pathway enrichment analysis were checked within each cluster [42], [44]. 
          Cluster 1 contains 132 genes. This group of genes is specifically responding 
to Serratia marcescens infection. The enriched KEGG pathways in this group are 
“Lysosome” and “Autophagy-animal”, as expected for the up-regulated 
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bacteria/pathogen defending reactions. The group contains aspartic peptidase, 
hydrolase, serine peptidase, and galactosidase.  
           Cluster 2 (65 genes) has the highest level of expression in infection of 
Enterococcus faecalis and relatively high expression with otorhabdus luminescens, 
Drechmeria coniospora and Harposporium sp. infections. The enriched biological 
process GO terms in this cluster are “gland morphogenesis”, “gland development”, 
and “pharyngeal gland morphogenesis”. In fact, a peroxidase, HPX-2, was 
expressed in pharyngeal to protect C. elegans from Enterococcus faecalis infection 
[52]. The enriched proteins feature in “superoxide dismutase activity”, consistent 
with literature report. 
        Cluster 3 (88 genes) defines a group of “bacteria pathogen responding” genes 
with high expression level in bacterial infection but low expression level in fungal 
infection. They are enriched in “biocynthesis of amino acids”, “lysosome”, 
“phagosome” and “Carbon metabolism” pathways.  
        Cluster 4 (101 genes) and Cluster 5 (104 genes) have opposite directions in 
expression. Cluster 4 genes have a higher expression when challenging with 
Enterococcus faecalis and otorhabdus luminescens while cluster 5 genes are down 
regulated when facing Enterococcus faecalis and otorhabdus luminescens. 
However, there was no enriched GO terms or KEGG pathways in these two 
clusters.  
 
Infection assays by pathogens to validate ESPs function 
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         To validate the pathogen-specific ESPs and their function, we challenged C. 
elegans with Serratia marcescens, Pseudomonas aeruginosa PA14 and 
Microbacterium nematophilum. All three are well-studied bacterial pathogens to 
C. elegans [31], [33, p. 14], [50], [53]–[59].  
         The Serratia marcescens infection assay revealed that grd-10, nas-20, cpi-2 
promote pathogen defense in C. elegans (Figure 3.6). Noticeably, grd-10 and nas-
20 are Cluster 1 members, which was defined as Serratia marcescens response 
genes. cpi-2 was found in Cluster 5, which is also highly expressed upon Serratia 
marcescens exposure.  
         We screened the same set of candidate genes to check the pathogen specific 
effect with Pseudomonas aeruginosa PA14 (Figure 3.7). Indeed, grd-10 and nas-
20 mutants are not significantly more vulnerable to PA14 infection. Instead, cpi-2, 
asp-6, clec-15, ilys-3, and spp-8 may be involved in defense mechanism upon 
PA14 infection.  
         Microbacterium nematophilum is a non-lethal pathogen causing tail swelling 
and constipation [31], [53]. Thus, the innate immune system of C. elegans should 
be active and up-regulated all the time during the whole infection process [31]. 
Indeed, we observed a very large group of genes that are associated with 
Microbacterium nematophilum infection (Figure 3.8), including ilys-3, cpi-2, dur-
1, cpr-2, grd-10, cdr-1, C25E10.8, clec-65, dgk-3, and dpy-5.  
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3.4 Discussion 
 
        Stage-specific proteomic profilings of excretome/secretome have been 
investigated in Strongyloides ratti and Brugia malayi [4], [18], [60]. In 
Strongyloides ratti, proteomic characterizations were performed to infective 
larvae, parasitic females and free-living stages. 140 proteins were shared in all 
stages and 196 infective larvae specific ESPs were identified [18]. In Brugia 
malayi, ESPs of L3, L3 to L4 molting, adult male, adult female, and microfilarial 
stage were profiled, leading to an identification of 852 proteins in total. The 
functional and component distribution remains similar across the developmental 
stages. Several immunologically important proteins were identified in the L3 to L4 
transition excretome/secretome, including abundant larval transcripts (ALT), a 
nematode polyprotein allergen (NPA) LL20, and DJ-1 family protein [4]. Stress-
response related proteins are also abundant in L3 to L4 infectome, including 
thioredoxin peroxidases and glutathione peroxidases [4].   
        We compared the stage-specific ESPs identified in our clustering method with 
the reported stage-specific ESPs from parasites. In general, the function annotation 
distributions in terms of protein families are very similar between species. It is 
hard to compare particular protein due to the missing annotation and function 
characterization. One successful example is that the intermediate filament protein 
is abundant in L3/L4 molting excretome/secretome of B. malayi [4]. Its C. elegans 
homologue, IFA-1, is characterized as a L3 stage specific ESP in cluster 7.  
Galectins are also abundant in L3/L4 molting ESPs in B. malayi while several 
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lectins members are L3 stage-specific ESPs of C. elegans [4]. The consistence in 
both protein function and expression stage suggest that some of the 
excretome/secretome functions may be shared between species.  
          We also demonstrated a trend of up-regulated proteases inhibitor expression 
in dauer formation and up-regulated proteases expression in dauer exit. Our results 
provided insights for dynamic dauer regulation. During dauer formation, cystatins, 
cpi-1, and cpi-2, are up regulated. We predicted the protein interactions with cpi-1 
and cpi-2 and found the predicted proteins that closely interact with cpi-1 and cpi-
2 are also abundant ESPs in proteomic results, including far-2, ttr-51, cpz-1, and 
cpl-1 [61]. This strongly supports the notion that the interaction networks around 
cpi-1 and cpi-2 play important role in ESPs. How this group of ESPs functions in 
dauer formation needs further investigation. K11D12.7 and C02F12.5 are another 
two serine-type endopeptidase inhibitors that are up-regulated in dauer formation. 
C02F12.5 is expressed in reproductive system suggesting that it may suppress the 
reproductive system activity and promote dauer formation [62].  
         C. elegans maintains homeostasis through innate immune system upon the 
infection of pathogens [33], [50]. A number of distinct protein families are 
involved in protective response to infections. Indeed, we observed all types of 
reported antimicrobial proteins are abundant in C. elegans ESPs, including 
nematode specific peptide group C families (nspc genes), saposin-like 
amoebapores (spp genes) as Antimicrobial peptides (AMPs), defensins (abf-2), 
and lysozymes (lys genes). AMPs and other secreted signals trigger the 
downstream signaling pathways in immune response [33], [63], [64]. 
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         Therefore, we proved a broad presence of all types of antimicrobial proteins 
in C. elegans excretome/secretome, suggesting ESPs are a complicated mixture 
and function to protect pathogen infection through innate immune response. 
Although there are shared pathogen defense signaling pathways, C. elegans also 
co-evolved with different pathogens and can exhibit pathogen-specific responses. 
Evidence has shown the C. elegans strains that are resistant to some natural 
pathogens may at the same time more sensitive to other pathogen infection, 
suggesting C. elegans may respond to specific pathogen with different signaling 
pathways [33], [63], [64].  
        We examined the expression profiles of ESPs upon five bacterial/fungal 
pathogen infections and clustered ESPs into five co-expression groups [8]. One co-
expression groups seems to be more sensitive in reaction to Serratia marcences. 
The other co-expression group seems to utilize a shared mechanism in defending 
bacterial pathogen other than fungal pathogens.  
       We confirmed the antimicrobial roles of several important protein family 
members in C. elegans ESPs by infection assays. Among these, lysozymes and 
cysteine protease inhibitors are two of the major groups of antimicrobial proteins. 
We have shown cpi-2 mutants are more sensitive to infection of all three bacterial 
pathogens while ilys-3 mutants are more vulnerable to PA14 and Microbacterium 
nematophilum infection but not to Serratia marcences. ilys-3 was identified in 
cluster 5, which has relatively low expression levels upon bacterial pathogen 
infections. However, we can observe a lot of lysozyme members, including lys-1, 
lys-2, lys-4, lys-7, and lys-8, are highly expressed during Serratia marcences 
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infection. The distribution of other key protein families also shows that each 
cluster contains different protein family members, suggesting that although the 
anti-infection mechanisms may be shared, C. elegans could response to specific 
pathogens with corresponding specialized family members.  
          In summary, our comparative method successfully characterized stage- and 
pathogen- specific excreted/secreted proteins. The stage-specific ESPs may be 
used to allow cross-species comparison with other parasites, helping to elucidate 
parasitism evolution and life stage transition mechanism. The pathogen-specific 
ESPs will promote the study of host-pathogen relationship and identify specific 
signaling pathways in innate immune system upon infection.  Our study also 
demonstrated the possibility to extend this comparative method to expression 
profiles under other conditions, for example, under stress or chemical stimuli. 
Another pivotal role of excreted/secreted proteins is to maintain homeostasis under 
stress, which is supported by the abundant presentence of peroxidases and 
superoxide dismutases to neutralize reactive oxygen species in C. elegans ESPs. 
Our comparative method allows quick selection of candidate genes to allow 
functional characterization. Together, studying dynamics of C. elegans ESPs 
composition is a key to understand how nematodes respond and adapt to fast 
changing environment and to elucidate the strategies to survive and reproduce in 
natural niche.  
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3.5 Materials and Methods 
 
Dauer Excreted/Secreted Proteins sample preparation 
        Dauers were cultured in liquid culture by adding dauer-inducing pheromone 
as previously described.  Dauers were then harvested by centrifuge and washed 
intensively for six times in M9 buffer. Dauers were left in 1 ml M9 buffer for 
incubation at 20°C for another 4 hours. Supernatant was collected and filtered by a 
0.22µm syringe filter unit.  
 
nanoLC-MS/MS and data process 
        All excreted/secreted protein samples were digested by LysC and Trypsin 
enzymes after the reduction and alkylation of Cysteines.  In-solution digested C. 
elegans ESP samples were chemically labeled using dimethyl labeling strategy [ ]. 
Briefly digested tryptic peptides are tagged on primary amines (N-terminus and 
amino group of lysine) using a mixture of cyanoborohydride and formaldehyde in 
their unlabeled and stable isotope-labeled forms. In this study samples were 
labeled with regular formaldehyde and cyanoborohydride for the light label (+28) 
and deuterated formaldehyde and cyanoborohydride to generates a mass increase 
of +32 for the intermediate label. Then the samples were mixed desalted and 
subjected to LC-MS/MS analysis on a nanoflow LC system, EASY-nLC II, 
(Thermo Fisher Scientific) coupled to a LTQ Orbitrap mass spectrometer (Thermo 
Fisher Scientific, Bremen, Germany) equipped with a Nanospray Flex ion source 
(Thermo Fisher Scientific). 
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        For the EASY-nLC II system, solvent A consisted of 97.8% H2O, 2% ACN, 
and 0.2% formic acid and solvent B consisted of 19.8% H2O, 80% ACN, and 
0.2% formic acid. Samples were directly loaded onto a 16-cm analytical HPLC 
column (75 mm ID) packed in-house with ReproSil-Pur C18AQ 3 um resin 
(120A° pore size, Dr. Maisch, Ammerbuch, Germany). The column was heated to 
45° C. The peptides were separated with a 120 min gradient at a flow rate of 350 
nL/min. The gradient was as follows: 2–30% Solvent B (110 min), 30–100% B (1 
min), and 100% B (9 min). Eluted peptides were then ionized using a standard 
coated silica tip (New Objective, Woburn, MA) as an electrospray emitter and 
introduced into the mass spectrometer.  The LTQ Orbitrap was operated in a data-
dependent mode, automatically alternating between a full-scan (m/z 300-1700) in 
the Orbitrap and subsequent MS/MS scans of the 15 most abundant peaks in the 
linear ion trap (Top15 method). Data acquisition was controlled by Xcalibur 2.0.7 
and Tune 2.4 software (Thermo Fisher Scientific). 
       Raw data was analyzed using MaxQuant (v. 1.5.3.30) [65], [66] Spectra were 
searched against C. elegans entries in UniProt as well as a contaminant database 
containing common proteins like trypsin and keratins. Precursor mass tolerance 
was 4.5 ppm after recalibration and fragment tolerance was 0.5 Da. 
Carbamidomethylation of cysteine was specified as a fixed modification and 
protein N-terminal acetylation and oxidation of methionine were specified as 
variable modifications. Trypsin was the specified digestion enzyme and up to two 
missed cleavages were allowed. Score were thresholded so as to achieve a 1% 
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FDR at the PSM, peptide, and protein levels as estimated by a decoy database. 
Match-between-runs, iBAQ, and LFQ quantitation were enabled. 
 
Soft clustering 
       Soft clustering was performed with the mFuzz package in R [1], [2]. Gene 
expression data were standardized before clustering, and cluster numbers were 
chosen based on cluster stability, minimum cluster centroid distance, and visual 
clarity of the clusters. Over-represented gene classes in clusters were determined 
by Fisher’s exact test by p<0.05. 
 
Heat maps 
       RNA-seq data of C. elegans dauer developmental stages were used as 
published. Expression values were centered and scaled for each gene. Heatmaps 
were drawn using the gplots and RColorBrewer packages in R. Heatmap 
dendrograms were drawn using correlation distances and average-linkage 
hierarchical clustering. 
 
Functional enrichment analysis 
        Gene ontology and KEGG analysis was performed with g:Profiler 
(e94_eg41_p11_9f195a1) [41]–[45], [67]. Significance was tested with g_SCS 
multiple testing correction with a threshold of 0.05. 
 
Bacteria strains 
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       E. coli HB101, E. coli OP50, Bacillus subtilis, Bacillus mycoides were 
cultured in LB at 37°C. Bacillus simplex, Bacillus megaterium, Microbacterium 
nematophilum CBX102 were obtained from Caenorhabditis Genetics Center 
(CGC) and cultured at 37°C. Pseudomonas aeruginosa PA14 was a gift from 
Dianne Newman lab and was cultured in LB at 37°C. Serratia marcescens 
db11was a gift from Elizabeth Glater lab.  
 
Animal strains 
      C. elegans wild type strain, N2 (Bristol), was maintained in lab followed the 
standard protocols on NGM plates with the E. coli strain OP50 as a food source 
(91). Strains obtained from the Caenorhabditis Genetics Center (CGC) were: 
RB667 far-2(ok435) III, RB1207 cpi-2(ok1256) V, RB2365 vit-2 (ok3211) X, 
VC2496 ilys-3 (ok3222) IV, VC687   
dur-1(ok1010) IV, RB2129 cpr-2(ok2833) V, RB2223 grd-10(ok3008) IV, RB2564 
nas-20(ok3572)V, RB2496 cdr-1(ok3456)V, VC1277 C25E10.8(ok1753)V, 
CB5635 bus-13(e2710)V, JN214 iff-2(tm393)/mIn1 [dpy-10(e128) mIs14]II, 
RB859 Y57A10C.6(ok693) II, RB1803 clec-65(ok2337)II, VC218 dgk-
3(gk110)III,  BC14615 dpy-5(e907) I;sEx14615 [rCes C02F12.5::GFP + 
pCeh361]. FX02213 asp-6 (tm2213) and FX03833 clec-15 (tm3833) were 
obtained from National Bioresource Project in Japan.  
 
Dauer entry assay on pheromone plates 
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        Dauer entry assay was performed as previously described. Crude pheromone 
was extracted from exhausted liquid culture medium, re-suspended with distilled 
water and stored at -20°C. Fresh pheromone plates (NGM-agar with added crude 
pheromone and no peptone) were made one day before experiment and left to dry 
overnight at room temperature. Overnight culture of E. coli OP50 was resuspended 
to 8 g/100 mL in S Basal buffer and heat at 100°C for 5 minutes. On the day of 
assay setup, 10 young adults were picked onto each plate, and allowed to lay eggs 
for 1 hour (approximately 50-60 eggs). After removing young adults, exact 
number of laid eggs was counted for each plate. 20 µl of heat-killed OP50 was 
added as food source. The numbers of dauers and non-dauers were counted after 
48 hours of incubation at 25.5°C. Each strain had 3 replicates.  
 
Pseudomonas aeruginosa PA14 slow killing assay 
      PA14 slow killing assay was performed as previously described. 10 µL 
overnight culture of PA14 was spread to each Slow-Killing agar plate. Plates were 
left to dry for 20 min at room temperature and followed by incubation at 37°C for 
24h.  Plates were transferred to incubate at 25°C for 24h. 40 µL of 100 X 5-fluoro-
2’-deoxyuridine (FUDR) was added to the edge of Slow-Killing plate and wait for 
diffusion for about 30 mins.  About 50 synchronized L4 larval stage worms were 
transferred to each assay plate and incubate at 25°C. Number of living worms were 
counted every 24 hours for about a week. Each condition had at least 3 replicates. 
Graphpad Prism 6 was used to plot survival curves and perform two-way ANOVA 
statistical tests.  
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Serratia marcescens db11 infection assay 
       Serratia marcescens db11 infection assay was done in a similar way to PA14 
infection assay. 10 µL of overnight cultere of db11 strain was spread to NGM 
plate and incubated at 37°C for 24h and 25°C for another 24h. 40 µL of 100 X 5-
fluoro-2’-deoxyuridine (FUDR) was added to the edge of NGM plate and wait for 
diffusion for about 30 mins. About 50 synchronized L4 larval stage worms were 
transferred to each assay plate and incubate at 25°C. Number of living worms were 
counted every 24 hours for about a week. Each condition had at least 3 replicates. 
Graphpad Prism 6 was used to plot survival curves and perform two-way ANOVA 
statistical tests. 
 
Microbacterium nematophilum CBX102 infection assay 
       Microbacterium nematophilum CBX102 infection assay was performed as 
previously described with modifications. 6 mL overnight culture of CBX102 was 
centrifuged at 3000g for 3 mins and resuspended in 1 mL M9 buffer. One pre-
packaged tube of Cy3 monoreactive dye (GE healthcare PA23001) was mixed 
with CBX102 and incubated for 1h at 4°C. Pellet was washed for 3 times with M9 
and resuspended to a final concentration of 200 mg/mL. 16 mg/mL 
Microbacterium nematophilum CBX102 was mixed with 16 mg/mL E. coli OP50 
at a 1:9 ratio. 20 µL of 10% M. nematophilum mixture was seeded to NGM plate 
and left to dry for a day at room temperature. About 30 L2/L3 larval stage worms 
were transferred to each mixed bacteria lawn plate. After 24 hours, worms were 
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scored for a tail-swelling phenotype.  Bump formation was checked if necessary 
under Zeiss LSM 710 Inverted confocal microscope. Each strain had 3 replicates. 
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3.6 Figures  
 
 
Figure 3.1. C. elegans ESPs can be classified into seven common expression 
profiles through developmental stages. Red lines are expression profiles for 
genes with high membership score.  
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Figure 3.2 Experimental design for dauer and developemental expression 
profiles with RNA-seq using daf-9(dh6) mutant. Samples were taken at: with no 
DA, “L2d” at 24 hours post hatch (hph), “L2d” at 26 hph, “dauer-committed L2d” 
at 34 hph, “fully developed dauers” at 60 hph; with DA added at 24 hph, “L3-
committing larvae” at 26 hph, “L4” at 34 hph. This is an unmodified figure from 
[49].  
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Figure 3.3 Hierarchical heat map for Dauer ESPs. Genes that were identified in 
dauer excretome/secretome and also were highly expressed in dauer expression 
profiles by RNA-seq (noDA.34 and noDA.60) were selected. They were further 
clustered by expression profile in heat map.  
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Figure 3.4 Dauer entry scores for predicted dauer-specific genes. Statistics: 
One-way ANOVA with Dunnett’s multiple comparisons. Ns, not significant, *, P 
<= 0.05, **, P <= 0.01, ***, P<= 0.001 ****, P <= 0.0001. 
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Figure 3.5 C. elegans ESPs can be classified into five common expression 
profiles in response to bacterial and fungal pathogens. Red lines are expression 
profiles for genes with high membership score.  
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Figure 3.6 Serratia marcences killing assay revealed several genes in innate 
immune response pathway. Statistics: two-way ANOVA with Sidak’s multiple 
comparisons test. Ns, not significant, *, P <= 0.05, **, P <= 0.01, ***, P<= 0.001 
****, P <= 0.0001. 
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Figure 3.7 Pseudomonas aeruginosa PA14 slow killing assay revealed several 
genes in defending PA14 infection. (A) infection of asp-6 knock out mutant and 
wild-type N2. (B) infection of spp-8 knock out mutant and wild-type N2. (C) 
infection of clec-15 knock out mutant and wild-type N2. (D) infection of ilys-3 
knock out mutant and wild-type N2. Statistics: two-way ANOVA with Sidak’s 
multiple comparisons test. Ns, not significant, *, P <= 0.05, **, P <= 0.01, ***, 
P<= 0.001 ****, P <= 0.0001. 
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Figure 3.8 Microbacterium nematophilum infections of ESP mutants. Statistics: 
One-way ANOVA with Dunnett’s multiple comparisons. Ns, not significant, *, P 
<= 0.05, **, P <= 0.01, ***, P<= 0.001 ****, P <= 0.0001. 
 
 
 
 
 
 
N2
bu
s-1
3
ily
s-3cp
i-2
du
r-1
cp
r-2
gr
d-1
0
cd
r-1
C2
5E
10
.8
iff
-2
Y5
7A
10
C.6
cle
c-6
5
dg
k-3
dp
y-5far
-2
vit
-2
na
s-2
0
as
p-6
cle
c-1
5
0.0
0.5
1.0
in
fe
ct
io
n 
ra
te
 b
y 
C
B
X1
02
 (%
)
****
ns
 124 
3.7 References: 
 
[1] E. Gómez-Orte et al., “Effect of the diet type and temperature on the C. elegans 
transcriptome,” Oncotarget, vol. 9, no. 11, pp. 9556–9571, Dec. 2017. 
[2] R. Shinya, H. Morisaka, T. Kikuchi, Y. Takeuchi, M. Ueda, and K. Futai, “Secretome 
Analysis of the Pine Wood Nematode Bursaphelenchus xylophilus Reveals the Tangled 
Roots of Parasitism and Its Potential for Molecular Mimicry,” PLoS One, vol. 8, no. 6, 
Jun. 2013. 
[3] S. Bellafiore, Z. Shen, M.-N. Rosso, P. Abad, P. Shih, and S. P. Briggs, “Direct 
identification of the Meloidogyne incognita secretome reveals proteins with host cell 
reprogramming potential,” PLoS Pathog., vol. 4, no. 10, p. e1000192, Oct. 2008. 
[4] S. Bennuru, R. Semnani, Z. Meng, J. M. C. Ribeiro, T. D. Veenstra, and T. B. Nutman, 
“Brugia malayi Excreted/Secreted Proteins at the Host/Parasite Interface: Stage- and 
Gender-Specific Proteomic Profiling,” PLoS Negl Trop Dis, vol. 3, no. 4, Apr. 2009. 
[5] D. Ditgen, E. M. Anandarajah, K. A. Meissner, N. Brattig, C. Wrenger, and E. Liebau, 
“Harnessing the Helminth Secretome for Therapeutic Immunomodulators,” BioMed 
Research International, 2014.  
[6] G. Coakley, A. H. Buck, and R. M. Maizels, “Host parasite communications—Messages 
from helminths for the immune system,” Mol Biochem Parasitol, vol. 208, no. 1, pp. 33–
40, Jul. 2016. 
[7] M. B. Gerstein et al., “Integrative analysis of the Caenorhabditis elegans genome by the 
modENCODE project,” Science, vol. 330, no. 6012, pp. 1775–1787, Dec. 2010. 
 125 
[8] I. Engelmann et al., “A comprehensive analysis of gene expression changes provoked by 
bacterial and fungal infection in C. elegans,” PLoS ONE, vol. 6, no. 5, p. e19055, 2011. 
[9] K. Jovic et al., “Temporal dynamics of gene expression in heat-stressed Caenorhabditis 
elegans,” PLOS ONE, vol. 12, no. 12, p. e0189445, Dec. 2017. 
[10]M. E. Boeck et al., “The time-resolved transcriptome of C. elegans,” Genome Res., vol. 
26, no. 10, pp. 1441–1450, Oct. 2016. 
[11]R. Di, H. Zhang, and M. A. Lawton, “Transcriptome Analysis of C. elegans Reveals 
Novel Targets for DON Cytotoxicity,” Toxins (Basel), vol. 10, no. 7, Jun. 2018. 
[12]J. W. Lightfoot, V. M. Chauhan, J. W. Aylott, and C. Rödelsperger, “Comparative 
transcriptomics of the nematode gut identifies global shifts in feeding mode and pathogen 
susceptibility,” BMC Res Notes, vol. 9, Mar. 2016. 
[13]R. P. Shivers, M. J. Youngman, and D. H. Kim, “Transcriptional responses to pathogens 
in Caenorhabditis elegans,” Curr Opin Microbiol, vol. 11, no. 3, pp. 251–256, Jun. 2008. 
[14]N. Wittenburg and R. Baumeister, “Thermal avoidance in Caenorhabditis elegans: An 
approach to the study of nociception,” PNAS, vol. 96, no. 18, pp. 10477–10482, Aug. 
1999. 
[15] “C elegans anatomy and lifecycle.pdf.” . 
[16]N. Fielenbach and A. Antebi, “C. elegans dauer formation and the molecular basis of 
plasticity,” Genes Dev, vol. 22, no. 16, pp. 2149–2165, Aug. 2008. 
[17]B. F. Kochin, J. J. Bull, and R. Antia, “Parasite Evolution and Life History Theory,” 
PLOS Biology, vol. 8, no. 10, p. e1000524, Oct. 2010. 
 126 
[18]H. Soblik et al., “Life Cycle Stage-resolved Proteomic Analysis of the 
Excretome/Secretome from Strongyloides ratti—Identification of Stage-specific 
Proteases,” Mol Cell Proteomics, vol. 10, no. 12, Dec. 2011. 
[19]D. Duneau and D. Ebert, “The role of moulting in parasite defence,” Proc Biol Sci, vol. 
279, no. 1740, pp. 3049–3054, Aug. 2012. 
[20]M. Crook, “The dauer hypothesis and the evolution of parasitism: 20 years on and still 
going strong,” Int. J. Parasitol., vol. 44, no. 1, pp. 1–8, Jan. 2014. 
[21]W. Wong, “How to Evolve into a Parasite,” Sci. Signal., vol. 2, no. 54, pp. ec26–ec26, 
Jan. 2009. 
[22]C. Dieterich and R. J. Sommer, “How to become a parasite - lessons from the genomes 
of nematodes,” Trends Genet., vol. 25, no. 5, pp. 203–209, May 2009. 
[23]A. Ogawa, A. Streit, A. Antebi, and R. J. Sommer, “A Conserved Endocrine Mechanism 
Controls the Formation of Dauer and Infective Larvae in Nematodes,” Current Biology, 
vol. 19, no. 1, pp. 67–71, Jan. 2009. 
[24]S. S. Lee and F. C. Schroeder, “Steroids as Central Regulators of Organismal 
Development and Lifespan,” PLOS Biology, vol. 10, no. 4, p. e1001307, Apr. 2012. 
[25]H. Aguilaniu, P. Fabrizio, and M. Witting, “The Role of Dafachronic Acid Signaling in 
Development and Longevity in Caenorhabditis elegans: Digging Deeper Using Cutting-
Edge Analytical Chemistry,” Front Endocrinol (Lausanne), vol. 7, Feb. 2016. 
[26]T.-M. Li et al., “No Significant Increase in the Δ4- and Δ7-Dafachronic Acid 
Concentration in the Long-Lived glp-1 Mutant, nor in the Mutants Defective in Dauer 
Formation,” G3: Genes, Genomes, Genetics, vol. 5, no. 7, pp. 1473–1479, Jul. 2015. 
 127 
[27]K. J. Dumas et al., “Functional divergence of dafachronic acid pathways in the control of 
C. elegans development and lifespan,” Dev Biol, vol. 340, no. 2, pp. 605–612, Apr. 2010. 
[28]L. Kumar and M. E. Futschik, “Mfuzz: A software package for soft clustering of 
microarray data,” Bioinformation, vol. 2, no. 1, pp. 5–7, May 2007. 
[29]M. E. Futschik and B. Carlisle, “Noise-robust soft clustering of gene expression time-
course data,” J. Bioinform. Comput. Biol., vol. 03, no. 04, pp. 965–988, Aug. 2005. 
[30]E. A. Abada, H. Sung, M. Dwivedi, B.-J. Park, S.-K. Lee, and J. Ahnn, “C. elegans 
behavior of preference choice on bacterial food,” Mol. Cells, vol. 28, no. 3, pp. 209–213, 
Sep. 2009. 
[31]J. Hodgkin, P. E. Kuwabara, and B. Corneliussen, “A novel bacterial pathogen, 
Microbacterium nematophilum, induces morphological change in the nematode C. 
elegans,” Current Biology, vol. 10, no. 24, pp. 1615–1618, Dec. 2000. 
[32]J. Höflich et al., “Loss of srf-3-encoded nucleotide sugar transporter activity in 
Caenorhabditis elegans alters surface antigenicity and prevents bacterial adherence,” J. 
Biol. Chem., vol. 279, no. 29, pp. 30440–30448, Jul. 2004. 
[33]C. Darby, “Interactions with microbial pathogens,” WormBook, 2005. 
[34]H. R. Nicholas and J. Hodgkin, “The ERK MAP Kinase Cascade Mediates Tail Swelling 
and a Protective Response to Rectal Infection in C. elegans,” Current Biology, vol. 14, 
no. 14, pp. 1256–1261, Jul. 2004. 
[35]S. Miyata, J. Begun, E. R. Troemel, and F. M. Ausubel, “DAF-16-Dependent 
Suppression of Immunity During Reproduction in Caenorhabditis elegans,” Genetics, 
vol. 178, no. 2, pp. 903–918, Feb. 2008. 
 128 
[36]M. E. Yanos, C. F. Bennett, and M. Kaeberlein, “Genome-Wide RNAi Longevity 
Screens in Caenorhabditis elegans,” Curr Genomics, vol. 13, no. 7, pp. 508–518, Nov. 
2012. 
[37]A. V. Samuelson, R. R. Klimczak, D. B. Thompson, C. E. Carr, and G. Ruvkun, 
“Identification of Caenorhabditis elegans genes regulating longevity using enhanced 
RNAi-sensitive strains,” Cold Spring Harb. Symp. Quant. Biol., vol. 72, pp. 489–497, 
2007. 
[38]C. L. Kurz and M.-W. Tan, “Regulation of aging and innate immunity in C. elegans,” 
Aging Cell, vol. 3, no. 4, pp. 185–193, 2004. 
[39]M. Ashburner et al., “Gene ontology: tool for the unification of biology. The Gene 
Ontology Consortium,” Nat. Genet., vol. 25, no. 1, pp. 25–29, May 2000. 
[40]H. Mi et al., “PANTHER version 11: expanded annotation data from Gene Ontology and 
Reactome pathways, and data analysis tool enhancements,” Nucleic Acids Res., vol. 45, 
no. D1, pp. D183–D189, 04 2017. 
[41]“g:Profiler—a web server for functional interpretation of gene lists (2016 update) | 
Nucleic Acids Research | Oxford Academic.”  
[42]J. Reimand, T. Arak, and J. Vilo, “g:Profiler—a web server for functional interpretation 
of gene lists (2011 update),” Nucleic Acids Res, vol. 39, no. suppl_2, pp. W307–W315, 
Jul. 2011. 
[43]M. Kanehisa and S. Goto, “KEGG: Kyoto Encyclopedia of Genes and Genomes,” 
Nucleic Acids Res, vol. 28, no. 1, pp. 27–30, Jan. 2000. 
 129 
[44]M. Kanehisa, M. Furumichi, M. Tanabe, Y. Sato, and K. Morishima, “KEGG: new 
perspectives on genomes, pathways, diseases and drugs,” Nucleic Acids Res., vol. 45, no. 
D1, pp. D353–D361, 04 2017. 
[45]M. Kanehisa, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “KEGG as a 
reference resource for gene and protein annotation,” Nucleic Acids Res, vol. 44, no. D1, 
pp. D457–D462, Jan. 2016. 
[46]S. K. Olson, G. Greenan, A. Desai, T. Müller-Reichert, and K. Oegema, “Hierarchical 
assembly of the eggshell and permeability barrier in C. elegans,” J Cell Biol, vol. 198, 
no. 4, pp. 731–748, Aug. 2012. 
[47]M. Crook, “The dauer hypothesis and the evolution of parasitism: 20 years on and still 
going strong,” Int J Parasitol, vol. 44, no. 1, pp. 1–8, Jan. 2014. 
[48]X. Karp, “Working with dauer larvae,” WormBook, pp. 1–19, Aug. 2018. 
[49]J. S. Lee, P.-Y. Shih, O. N. Schaedel, P. Quintero-Cadena, A. K. Rogers, and P. W. 
Sternberg, “FMRFamide-like peptides expand the behavioral repertoire of a densely 
connected nervous system,” PNAS, vol. 114, no. 50, pp. E10726–E10735, Dec. 2017. 
[50]L. B. Cohen and E. R. Troemel, “Microbial pathogenesis and host defense in the 
nematode C. elegans,” Curr Opin Microbiol, vol. 0, pp. 94–101, Feb. 2015. 
[51]N. Pujol et al., “Anti-Fungal Innate Immunity in C. elegans Is Enhanced by Evolutionary 
Diversification of Antimicrobial Peptides,” PLoS Pathog, vol. 4, no. 7, Jul. 2008. 
[52]Y. Liu, K. G. Kaval, A. van Hoof, and D. A. Garsin, “Heme peroxidase HPX-2 protects 
Caenorhabditis elegans from pathogens,” PLOS Genetics, vol. 15, no. 1, p. e1007944, 
Jan. 2019. 
 130 
[53]M. J. Gravato-Nobre, F. Vaz, S. Filipe, R. Chalmers, and J. Hodgkin, “The Invertebrate 
Lysozyme Effector ILYS-3 Is Systemically Activated in Response to Danger Signals and 
Confers Antimicrobial Protection in C. elegans,” PLOS Pathogens, vol. 12, no. 8, p. 
e1005826, Aug. 2016. 
[54]H. Schulenburg and J. J. Ewbank, “Diversity and specificity in the interaction between 
Caenorhabditis elegans and the pathogen Serratia marcescens,” BMC Evolutionary 
Biology, vol. 4, no. 1, p. 49, Nov. 2004. 
[55]E. Pradel, Y. Zhang, N. Pujol, T. Matsuyama, C. I. Bargmann, and J. J. Ewbank, 
“Detection and avoidance of a natural product from the pathogenic bacterium Serratia 
marcescens by Caenorhabditis elegans,” PNAS, vol. 104, no. 7, pp. 2295–2300, Feb. 
2007. 
[56]R. L. Feinbaum et al., “Genome-Wide Identification of Pseudomonas aeruginosa 
Virulence-Related Genes Using a Caenorhabditis elegans Infection Model,” PLOS 
Pathogens, vol. 8, no. 7, p. e1002813, Jul. 2012. 
[57]N. V. Kirienko, B. O. Cezairliyan, F. M. Ausubel, and J. R. Powell, “Pseudomonas 
aeruginosa PA14 pathogenesis in Caenorhabditis elegans,” Methods Mol. Biol., vol. 
1149, pp. 653–669, 2014. 
[58]M. W. Robinson, R. Greig, K. A. Beattie, D. J. Lamont, and B. Connolly, “Comparative 
analysis of the excretory-secretory proteome of the muscle larva of Trichinella 
pseudospiralis and Trichinella spiralis,” Int. J. Parasitol., vol. 37, no. 2, pp. 139–148, 
Feb. 2007. 
 131 
[59]M.-W. Tan, S. Mahajan-Miklos, and F. M. Ausubel, “Killing of Caenorhabditis elegans 
by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis,” Proc 
Natl Acad Sci U S A, vol. 96, no. 2, pp. 715–720, Jan. 1999. 
[60]J. P. Hewitson et al., “The secretome of the filarial parasite, Brugia malayi: proteomic 
profile of adult excretory-secretory products,” Mol. Biochem. Parasitol., vol. 160, no. 1, 
pp. 8–21, Jul. 2008. 
[61]D. Szklarczyk et al., “The STRING database in 2017: quality-controlled protein–protein 
association networks, made broadly accessible,” Nucleic Acids Res, vol. 45, no. Database 
issue, pp. D362–D368, Jan. 2017. 
[62]J. W. Ziel, D. Q. Matus, and D. R. Sherwood, “An expression screen for RhoGEF genes 
involved in C. elegans gonadogenesis,” Gene Expr Patterns, vol. 9, no. 6, pp. 397–403, 
Sep. 2009. 
[63]J. Ewbank, “Signaling in the immune response,” WormBook, 2006. 
[64]D. H. Kim, “Signaling in the innate immune response,” WormBook, pp. 1–35, Aug. 
2018. 
[65]J. Cox and M. Mann, “MaxQuant enables high peptide identification rates, 
individualized p.p.b.-range mass accuracies and proteome-wide protein quantification,” 
Nature Biotechnology, vol. 26, no. 12, pp. 1367–1372, Dec. 2008. 
[66]J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen, and M. Mann, 
“Andromeda: a peptide search engine integrated into the MaxQuant environment,” J. 
Proteome Res., vol. 10, no. 4, pp. 1794–1805, Apr. 2011. 
 132 
[67]J. Reimand, M. Kull, H. Peterson, J. Hansen, and J. Vilo, “g:Profiler—a web-based 
toolset for functional profiling of gene lists from large-scale experiments,” Nucleic Acids 
Res, vol. 35, no. suppl_2, pp. W193–W200, Jul. 2007. 
 
 
 133 
C h a p t e r  4  
CHARACTERIZING EXCRETED/SECRETED PROTEINS OF A 
CAENORHABDITIS ELEGANS SIBLING SPECIES, 
CAENORHABDITIS INOPINATA 
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4.1 Abstract 
 
The recent discovery of a Caenorhabditis elegans sibling species, Caenorhabditis 
inopinata, allows deeply comparative study for evolutional interpretation. The 
excretome/secretome of C. inopinata has not been characterized. We took advantage of the 
sensitive and high-throughput technique of nanoscale liquid chromatography coupled to 
tandem mass spectrometry (nano LC-MS/MS) to directly characterize the protein 
components of C. inopinata excretome/secretome. Functional annotations reveal several 
protein families including C-type lectins, Cathepsin Z, Cathepsin B family, transthyretin, 
and saposin-like families, suggesting ESPs play critical roles in regulating innate immune 
response. We compared C. inopinata excretome/secretome with C. elegans. The 
compositions of protein families are highly conserved across species, suggesting that the 
sibling species shares common mechanism with C. elegans to respond to environmental 
stimuli.  
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4.2 Introduction 
 
        Caenorhabditis inopinata n. sp. was found very recently in the fresh fig syconia in 
Japan [1], [2]. The phylogenetic analyses found that C. inopinata is the closest species to C. 
elegans in evolution, which diverged about 10.5 million years ago [1]. C. inopinata feeds 
on the bacteria in the fig syconia and proliferates. Dauer of C. inopinata can translocate to 
new habitat by attaching to mutualistic pollinating wasp. C. inopinata shares several 
morphological features with other fig-associated nematodes, indicating that C. inopinata 
coevolved with Fig Ficus syconia and is adapted to fig syconia environment. The genome 
model of C. inopinata found more than 95% of genes have homologs in C. elegans and the 
essential pathways, including dauer formation and insulin/insulin like growth factor 
signaling, are highly conserved [1], [2].  
         Since C. inopinata is the sibling species to C. elegans, we wanted to characterize C. 
inopinata ESPs using the same HPLC-MS/MS method to allow direct comparison of ESPs 
between species and to elucidate the evolutions of how species adapt to their habit 
environments [1]. The study of C. inopinata excretome/secretome itself also provides rich 
information on how this nematode regulates the metabolism and morphology and how they 
benefit from the mutualism.  
         Thus, we performed a high throughput proteomic characterization of C. inopinata 
excreted/secreted proteins. A total number of 585 proteins were identified using a mix stage 
population of C. inopinata. The size of the excretome/secretome is very close to C. 
elegans. We performed functional annotations of Gene Ontology and KEGG pathways [3]–
[5], [6, p. 2], [7]–[9]. The structure of C. inopinata excretome/secretome in terms of GO 
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molecular functions, biological processes and protein families is highly conserved. This is 
also a great example demonstrating how annotation of C. elegans ESPs can benefit 
annotation to proteins in the new gene model.  
        The main pathways associated with C. inopinata are “innate immune response” and 
“metabolism”, in consistent with the hypothesis that ESPs function continuously to fight 
against environmental changes. Major protein families are also conserved, including 
peptidases, lectins, and lysozymes. By orthologous comparison, majority of ESPs have 
homologues in both species. We only observed a slight expansion in cuticle collagen 
proteins and a slight shrink in pharyngeal gland toxin related proteins in C. inopinata. In 
general, the highly conserved C. inopinata and C. elegans excretomes/secretomes suggest 
they share common mechanisms to maintain homeostasis. However, particular protein 
functions need to be investigated more carefully in specific signaling pathways since 
modification of essential functions is the key to adapt to specialized niche [10]–[12] .  
         We further expanded the comparisons to other parasitic nematodes in order to explain 
the evolution of parasitism [11]–[16]. We demonstrated that the functional structures of 
ESPs are similar for parasitic nematodes with distinct lifestyles and for free-living 
nematodes. Majority of the protein families are shared among all the species, although the 
numbers of protein family members inside each species could vary. Among these, cysteine-
type peptidase, transthyretin-like superfamily, pharyngeal gland toxin related proteins, and 
lysosomes vary the most across species. C. elegans C-type lectin family is expanded in 
ESPs, suggesting the life style of C. elegans with complicated soil bacteria populations 
may require a broader spectrum of immune-regulation molecules [17]–[20].  
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4.3 Results 
 
Profiling the components of C. inopinata Eecreted/Secreted Proteins (ESPs) with 
nanoLC-MS/MS 
        Nano-liquid chromatography coupled with tandem mass spectrometry (nanoLC-
MS/MS) was performed to directly characterize the protein components of C. inopinata.  
        The wild type of C. inopinata strain was grown on 50 large NGM plates with pre-
seeded E. coli OP50 in each Mass-Spec sample preparation batch. Worms were growing at 
25 °C to the point of food depletion. Contaminated plates were discarded. Mixed staged C. 
inopinata worms were collected and washed intensively six times with M9 buffer. Then 
nematodes were incubated in 1 mL M9 at 25 °C for 4 hours. Supernatant was collected by 
centrifuge and filtered by a 0.22µm syringe filter. We treated this as the unconcentrated C. 
inopinata excreted/secreted proteins sample. The concentration of unconcentrated C. 
inopinata was measured and followed by lysyl endopeptidase/trypsin digestion and was 
subjected to nanoLC-MS/MS for peptide characterization.   
       In summary, a total of 585 C. inopinata excreted/secreted proteins were characterized 
with a majority of proteins identified with two or more specific peptides. The detailed 
composition of C. inopinata ESPs was provided in a concise form in Appendix table 4.1 
with all details from Mass-Spec (Appendix table 4.1). The size of detected C. inopinata 
excretome/secretome was similar to what we found about C. elegans excretome/secretome. 
Also, similar proteomic methods performed to other parasites reported a similar size of 
parasites excretome/secretome. An excretome/secretome proteomic study with 
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Strongyloides ratti identified 586 proteins in total and 852 proteins were characterized in 
Brugia malayi ESPs  [15], [16].  
       The characterized C. inopinata ESPs covered about 2.7% (585 out of 21608) of the C. 
inopinata genes while C. elegans ESPs covered 2.5% of the C. elegans genome. In general, 
C. inopinata genome is very similar to its sibling species, C. elegans. More than 95 percent 
of the C. inopinata genes have orthologues in C. elegans. The main difference between 
these two genomes was the sex determination genes since C. inopinata has a XO 
male/female sexual system while C. elegans is hermaphrodite/male. Considering the high 
conservation between genomes and similar free-living life styles, we would expect the sizes 
of excretome/secretome to be close to each other.  
 
Gene ontology analysis  
       We conducted Gene Ontology (GO) term analysis to the list of 585 C. inopinata 
excreted/secreted proteins [4], [21]. Each of the excreted/secreted proteins was BLASTed 
against NCBI with BLASTp. The annotations to the top blast hits were added and 
InterProScan was performed by Blast2GO (Figure 4.1) [5, p. 2], [6], [22].   
        Majority of the excreted/secreted proteins are around a length of 300 amino acids. By 
BLAST search, about 78% of the excreted/secreted proteins were successful annotated. 9% 
of the excreted/secreted proteins were not returned with a BLAST best hit (Figure 4.2). For 
the sequences with returned BLAST hits, the coverage is around 97% on average and most 
of the sequences returned multiple BLAST results, suggesting the identified 
excreted/secreted proteins are evolutionally conserved between species (Figure 4.3). The 
annotation to C. inopinata ESPs benefits significantly from the homologous models to C. 
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elegans ESPs. The annotation levels in some parasites are limited by the lack of whole 
genome sequence and gene models [23]–[27]. This demonstrated how characterization of 
C. elegans ESPs can be used to help annotate the parasites ESPs.   
         The BLAST results were mainly from the closest nematodes relatives including C. 
elegans, C. briggsae, C. remanei, and C. brenneri. The BLAST top-Hits were mainly from 
C. elegans, confirming that C. inopinata indeed is the sibling species of C. elegans (Figure 
4.4).  
        GO terms were successfully assigned to C. inopinata sequences. About half of the 
sequences in excretome/secretomes were assigned with more than one GO term. A total of 
1468 GO terms were annotated to C. inopinata ESPs. About 75% of the GO terms were 
annotated to level-3 GO terms or above, suggesting the annotation level in C. inopinata is 
good (Figure 4.5). 
        GO terms of biological processes include several interesting major categories. The 
first group contains GO terms of “immune system process”, “response to stress”. This 
presence of this group of GO terms is consistent with the finding of similar GO terms 
enriched in C. elegans ESPs. The equivalent C. elegans GO term group contains GO terms 
like “defense response to Gram-positive bacterium”, “innate immune response” and 
“defense response to Gram-negative bacterium”. This group of excreted/secreted proteins is 
expected to regulate innate immune response and help nutrition uptake or removing 
pathogens/cell debris probably through lysosome and phagolysosome. The second 
interesting group contains GO terms of “cell adhesion”, and “vesicle-mediated transport”, 
indicating the proteins in this group may be involved in extracellular functions. This is 
consistent with our expectation that ESPs are mainly active directly at the nematode-
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environment surface. Another major group of GO terms are associated with metabolic 
pathways, including “small molecule metabolic process”, “carbohydrate metabolic 
process”, and “lipid metabolic process”. This subgroup of proteins may function as critical 
enzymes allowing the modification of metabolism to adapt to fast changing environment 
(Figure 4.6). 
       GO terms of molecular function include “peptidase activity”, “lyase activity”, and 
“hydrolase activity” (Figure 4.7). In C. elegans excretome/secretome, GO terms enriched 
in molecular function are mainly lysozymes and proteases and proteases inhibitors, 
including galactosidase activity, serine-type exopeptidase activity, lysozyme activity, 
peptidoglycan muralytic activity, aspartic-type endopeptidase activity, and cysteine-type 
endopeptidase activity. The molecular function GO terms in C. inopinata suggest that 
proteases and proteases inhibitors are important components in C. inopinata 
excretome/secretome.  
       KEGG pathway analysis was performed to identify the related pathways to C. 
inopinata ESPs. Majority of the result are related to metabolism and protein degradation 
(Figure 4.8 and Appendix table 4.2). In C. elegans, innate immune system pathway and 
protein degradation pathway are the most over-represented KEGG pathway. This similarity 
suggests one major role of ESPs is to continuously fight with the changing environment, 
especially defending infection of bacteria pathogens.  
 
Brief overview of C. inopinata Excretome/Secretome structure shows several protein 
families are main players 
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      The most abundant proteins identified in C. inopinata ESPs under the standard culture 
condition were listed (Table 4.1 and Figure 4.9). C. inopinata excretome/secretome 
shared many common features with C. elegans ESPs. Both excretome/secretome contains 
proteins from lysozyme family, transthyretin-like family, lectins, proteases, and proteases 
inhibitors. The similarity in C. inopinata ESPs and C. elegans ESPs indicated that these 
two species are highly conserved in evolution.  
 
Signal peptide detection in C. inopinata 
          The presence of a signal peptide and presence of signal peptide cleavage sites can be 
used to predict whether a protein is secreted or not [28], [29]. Thus, we used SignalP5.0 to 
predict signal peptide presence for each excreted/secreted protein in C. inopinata [28], 
[29]. 163 of 585 genes were predicted to contain a signal peptide sequence, representing 
27.8% of the total identified C. inopinata ESP. In C. elegans, however, 72.3% of identified 
C. elegans ESPs were predicted to contain signal peptide. In other parasitic nematodes, 
55% of B. malayi ESPs are predicted to have signal peptide and 41% of B. xylophilus ESPs 
are predicted to have signal peptide [13], [15], [30].  
          Surprisingly, the signal peptide presence is much lower in C. inopinata than other 
species. The main difference in excretome/secretome preparation between C. inopinata and 
C. elegans is that C. inopinata was cultured on plates instead of liquid culture. However, in 
both cases, we checked the worm viabilities before collection and followed by intensive 
wash to minimize the content of soluble worm lysate. Thus, the possibility of all these 
proteins without signal peptide are from worm lysate contamination is low.  
 142 
           The top GO terms showed that actins, RNA binding proteins and ribosomes are 
abundant in C. inopinata ESPs. This may be surprising and can be easily interpreted to 
cellular components. However, studies in either C. elegans ESPs and parasitic nematodes 
ESPs showed that the presence of actins, histones, and RNA binding proteins are common. 
By comparing with whole worm lysate proteomic results, these are proved to be truly 
enriched in excreted/secreted proteins and may be associated with exosome secretion 
pathway in various organisms [13], [15], [31], [32].  
          Literatures reported many parasitic excreted/secreted proteins do not have a classical 
signal peptide. These proteins may contain unknown secretory signals or they could be 
secreted through non-canonical secretory pathways. For example, macrophage migration 
inhibitory factor homolog in B. malayi was proven to be exported despite lacking a signal 
peptide [15], [30]. Helminth parasites were shown to produce exosome, carrying 
immunoglobulins and metabolic enzymes. Exosome proteome of E. caproni even 
explained 54% of the characterized secretome [32]–[35]. Thus, non-canonical secretion 
mechanism might be a common feature in nematodes. Whether the secretion of C. 
inopinata rely more the non-classical secretion needs to be further investigated.  
 
Pfam domain search and InterproScan sequence search 
      In order to compare the similarities and differences between C. inopinata and C. 
elegans, we searched against Pfam and InterPro database to identify domain structure and 
protein family information for each protein sequence (Figure 4.10 and Figure 4.11) [22], 
[36], [37]. Transthyretin-like, Aspartic peptidase A1 family, C-type lectins, and glycoside 
hydrolase are the major protein familes in C. inopinata. The plot from enzyme annotation 
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gave back the same result (Figure 4.12). Network of protein-protein interactions was also 
plotted. And in consistent with C. elegans protein-protein network, Cathepsin Z family and 
Cathepsin B family members are in the center position to interact with other ESPs.  
       In order to visualize the protein family distribution in C. inopinata and C. elegans, we 
took protein sequences from two species and ran all versus all BLAST. Based on sequence 
similarities, a BLAST map clearly showed the protein families in two species (Figure 4.13). 
The C. inopinata proteins were labeled in yellow. From the map, the C. inopinata proteins 
and the C. elegans proteins were evenly distributed, suggesting the high similarity in the 
composition of excretomes/secretomes. There are two groups of proteins that showed slight 
differences between these two species. C. elegans excretome/secretome has more C-type 
lectins while C. inopinata has more cuticle collagen proteins. The ten most abuandant 
protein families are labeled in Figure 4.13, showing the highly conserved structures 
between excretomes/secretomes. 
 
Protease and proteases inhibitors in C. inopinata 
      Peptidases contribute to host specificity, host range and virulence. To detect putative 
proteases (also termed peptidase or proteinases) and proteases inhibitors, a total of 585 
excreted/secreted protein sequences were subjected to the MEROPS BLAST search and 
classified into detailed MEROPS proteases or proteases inhibitor families (E-value cutoff 
of 1e-4). This approach predicted 110 putative proteases and 37 proteases inhibitors, 
contributing to 25.1% of annotated genes in list (Appendix table 4.3). The percentages of 
peptidases in C. elegans, B. xylophilus, M. incognita, B. malayi are 13.3%, 10.6%, 6.4%, 
and 5.2%, respectively [6,8]. 
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Detection of Carbohydrate-active enzymes 
       Carbohydrate-active enzymes (CAZymes) are key regulators to metabolism of 
glycoconjugates, oligosaccharides and polysaccharides [38]. The size and diversity of 
CAZymes can provide clues to nematode nutritional strategy and host specificity [1], [13]. 
dbCAN (automated CAZyme annotation) database was searched to identify CAZymes in 
C. inopinata ESPs. With HMMER3 search, 17 glycoside hydrolases (GH) were identified 
in C. elegans ESPs, belonging to Glycoside Hydrolase, GlycosylTransferase and 
Carbohydrate Esterase families (Table 4.2). The total number of identified CAZymes is 
very close to what is found in C. elegans (17 glycoside hydrolases). However, the 
CAZymes are more diverse in C. inopinata. Whether the CAZymes in C. inopinata have 
associated functions with degradation of bacterium in fig or binding to wasps needs to be 
further investigated.  
 
Orthogroups between C. inopinata and C. elegans for cross-species comparison 
        Orthologous groups permit comparative evolutionary and functional analyses [39]. A 
combined 1098 genes from C. inopinata and C. elegans excretomes/secretomes were used 
to find orthogroups. 473 genes, which represent 43.1% of the total number of genes, were 
successfully assigned into 182 orthogroups with a mean orthogroup size of 2.6. There was 
no species-specific orthogroups, suggesting C. inopinata ESPs composition is very similar 
to C. elegans ESPs composition (Table 4.3).  
        Detailed orthogroups between C. inopinata and C. elegans were provided in Appendix 
table 4.3 (Appendix Table 4.3). Almost all orthogroups have similar numbers of proteins 
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across species. We can only observe a slight expansion in cuticle collagen proteins 
(OG0000001) and a slight shrink in pharyngeal gland toxin related proteins (OG0000006) 
in C. inopinata. In general, the orthogroups provided strong evidence that C. inopinata 
excretome/secretome share common features with C. elegans. 
 
Comparisons with other parasitic nematodes ESPs  
       Similar comparisons of secretome profiles of Bruga malayi, Bursaphelenchus 
xylophilus, Strongyloide ratti were performed to C. elegans ESPs in order to investigate 
species differences [13], [15], [16]. These three species were picked out since their 
excretome/secretome profiles were of the best qualities, characterizing at least around 500 
proteins. The phylogenetic relationships of nematodes were shown (Figure 4.14, right 
side).  
 
Orthogroups between B. malayi and C. elegans  
        1365 genes from B. malayi and C. elegans excretomes/secretomes were used to find 
orthogroups. 221 genes, which represent only 16.2% of the total number of genes, were 
assigned into 78 orthogroups with a mean orthogroup size of 2.8.  
         Among the orthogroups, we can observe B. malayi has expanded protein families in 
cuticlin and endochitinase. C. elegans ESPs contains expansion in lectins, trypsin 
inhibitors, and SCP-like extracellular proteins.  
 
Orthogroups between B. xylophilus and C. elegans  
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        2028 genes from B. malayi and C. elegans excretomes/secretomes were used to find 
orthogroups. 508 genes, which represent 25% of the total number of genes, were assigned 
into 179 orthogroups with a mean orthogroup size of 2.8.  
        5 species-specific orthogroups were identified. Two C. elegans specific orthogroups 
are lysozymes (lys-1, lys-2, lys-7, lys-8) and SCP-Like extracellular proteins expressed in 
pharyngeal gland cell (scl-14, scl-2, scl-3, scl-5). Three B. xylophilus specific orthogroups 
are lysozyme-like proteins, aspartic proteases and SCP-Like extracellular protein. Shared 
orthogroup OG0000005 contains 1 B. xylophilus gene and 8 C. elegans aspartic protease 
members. These observations suggest that, in general, major protein families are conserved 
between B.xylophilus and C. elegans. But the protein structures diverged between species 
and evolved to function in different life styles.  
        Among the shared orthogroups, we can observe that B. xylophilus has several 
expanded protein families. OG0000000 contained 24 B. xylophilus cysteine-type peptidases 
genes and 1 C. elegans gene. OG0000001 contained 11 B.xylophilus aminopeptidase genes 
and 1 C. elegans gene. OG0000004 contained 7 B. xylophilus and 1 C. elegans gene. 
OG0000006 contained 6 B. xylophilus glutathione S- transferase genes and 1 C. elegans 
gene. OG0000007 contained 5 B. xylophilus Neprillysin metallopeptidase family genes and 
1 C. elegans gene. OG0000009 contained 5 B. xylophilus cuticlin-like genes and 1 C. 
elegans gene.  
          C. elegans excretome/secretome has an expansion in pharyngeal gland toxin-related 
gene. OG0000002 includes 9 C. elegans pharyngeal gland toxin-related gene and 1 B. 
xylophilus gene.   
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Orthogroups between S. ratti and C. elegans  
        946 genes from S. ratti and C. elegans excretomes/secretomes were used to find 
orthogroups. 297 genes, which represent 31.4% of the total number of genes, were assigned 
to 115 orthogroups with a mean orthogroup size of 2.6. There was no species-specific 
orthogroup identified.  
         Among the shared orthogroups, we can observe S. ratti has expanded protein families 
in transthyretin-like superfamily. C. elegans ESPs contains expansion in a group of 
hydrolases that are expressed in intestine and SCP-like extracellular proteins. 
 
Orthogroups across 5 nematodes species  
        3898 genes from Caenorhabditis elegans, Caenorhabditis inopinata, Bruga malayi, 
Bursaphelenchus xylophilus, Strongyloide ratti excretomes/secretomes were combined 
together and used to find orthogroups [13], [16], [30]. 2059 genes, which represent 52.8% 
of the total number of genes, were assigned into 523 orthogroups with a mean orthogroup 
size of 3.9. There was no species-specific orthogroup identified.  
         Among the shared orthogroups, several gene families obviously expanded in one 
species than the others (Appendix Table 4.4). Gene families expanded in B. xylophilus are 
cysteine-type peptidase, transthyretin-like superfamily and aminopeptidase. A group of 
immunoglobulin I-set domain containing proteins expanded in B. malayi. C. elegans has 
more C-type lectins genes than other species.  
         Based on the excretome/secretome orthogroups, we could also rebuild a phylogenetic 
tree of nematodes. The rebuilt tree (Figure 4.14, left side) is slightly different from species 
phylogenetic relationships based on small subunit (SSU) homologies (Figure 4.14, right 
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side) [13]. B. malayi and S. ratti are both vertebrate parasites and in the rebuilt ESPs tree, 
these two vertebrate parasites share more similarities than others. This is an interesting 
observation showing the composition of ESPs may be associated with life styles. This 
hypothesis can only be tested further if there are more well-characterized 
excretomes/secretomes of parasites.   
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4.4 Discussion 
 
        We used the same proteomic method to characterize ESPs of C. inopinata, the sibling 
species of C. elegans. Comparison of ESPs between two species confirmed that ESPs 
functional structures are similar across species and are highly conserved in terms of protein 
family categories and related pathways. We took a further step to expand the comparison to 
many characterized parasites excretomes/secretomes. Again, half of the ESPs have at least 
one homolog in at least one species.  
        How does parasitism evolve? We first take a look at the genes that failed to be 
assigned into orthologous groups. However, majority of the unassigned genes are 
uncharacterized and very little information is known about their immune regulation roles. 
One direction to study parasitism is to utilize this subset of unassigned genes in parasites 
and characterize their functions, as they may conduct novel mechanisms in evading host 
immune system. Secondly, we carefully examined the conserved gene groups since the 
general mechanism may be shared across species but parasites may evolve and make 
critical modifications to gain novel feature to allow infection and invasion of host. One 
excellent example is demonstrated by B. malayi cpi-2. Bm-CPI-2 possess two conserved 
functional domains, one to inhibit papain-like proteases and the other one to inhibit 
asparaginyl endopeptidase (AEP) and therefore inhibits antigen processing by human B 
cells. In contrast, C. elegans homologs of cystatins, cpi-1 and cpi-2, are not functional to 
block AEP. Thus, B. malayi CPI-2 may convergently evolved to be able to function in 
mammalian environment [40]. Thirdly, gene duplication events for major protein families 
in excretome/secretome provide another possibility to allow species-specific antigen 
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recognition and process. For example, lysozymes and proteases are broadly present in 
many free-living and parasitic nematodes. Gene duplication events happened several times 
and may provide clues for how parasite genes diverged to gain parasitism. 
        In summary, the proteomic characterizations of C. elegans and C. inopinata serve as a 
great platform for comparative studies in parasites. First of all, many parasite genomes 
were poorly annotated, limiting the power to identify excreted/secreted proteins. Based on 
C. elegans ESPs, we could help to annotate the earlier hypothetical proteins in parasites and 
also confirm their presence in excretome/secretome. Second, studying the ESPs evolution 
between free-living nematodes and parasites would provide clues for how parasitism is 
acquired and evolved. 
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4.5 Materials and Methods 
 
Excreted/Secreted Proteins Preparation 
       The wild type of C. inopinata strain, NK74SC, was a gift from Taisei Kikuchi. C. 
inopinata strain was grown using a similar protocol to standard lab maintain method of C. 
elegans. For preparing the large number of animals required for Mass-spec, 10 gravid 
females from a 1-week-old culture were picked to d=10cm NGM plates with pre-seeded E. 
coli OP50. 50 large NGM plates were used in each Mass-spec sample preparation batch. 
Plates with C. inopinata were kept at 25 degree and left to grow to the point of almost 
depleting of bacteria food. Contaminated plates were discarded and M9 buffer was used to 
wash C. inopinata worms off the rest of the plates. The collected worms were washed 
intensively for six times with M9 and were left in 1ml M9 in the last step and incubated at 
25 degree for 4 hours. The supernatant was collected and filtered by a 0.22µm syringe 
filter.  
 
NanoLC-MS/MS and data process 
       In-solution digested C. inopinata ESP samples were subjected to LC-MS/MS analysis 
on a nanoflow LC system, EASY-nLC 1000, (Thermo Fisher Scientific) coupled to a LTQ 
Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). 
For the EASY-nLC 1000 system, solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% 
formic acid and solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. 
Samples were directly loaded onto a 25-cm analytical HPLC column (50 µm ID) packed 
in-house with ReproSil-Pur C18AQ 3 µm resin (120A° pore size, Dr. Maisch, Ammerbuch, 
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Germany). The column was heated to 55° C. The peptides were separated with a 125min 
gradient at a flow rate of 220 nL/min. The gradient was as follows: 2–30% Solvent B (115 
min), 30–100% B (1 min), and 100% B (9 min). Eluted peptides were then ionized using a 
Nanospray Flex ion source (Thermo Fisher Scientific) and introduced into the mass 
spectrometer.  The LTQ Orbitrap Elite was operated in a data-dependent mode, 
automatically alternating between a full-scan (m/z 400-1600, 120K resolution) in the 
Orbitrap and subsequent MS/MS scans of the 20 most abundant peaks in the linear ion trap 
(Top20 method). Data acquisition was controlled by Xcalibur 2.2 and LTQ Tune Plus 2.7 
software (Thermo Fisher Scientific). 
         Raw data was analyzed using MaxQuant (v. 1.5.3.30) [41], [42]. Spectra were 
searched against C.inopinata genome assembly [1] as well as a contaminant database 
containing common proteins like trypsin and keratins. Precursor mass tolerance was 4.5 
ppm after recalibration and fragment tolerance was 0.5 Da. Carbamidomethylation of 
cysteine was specified as a fixed modification and protein N-terminal acetylation and 
oxidation of methionine were specified as variable modifications. Trypsin was the specified 
digestion enzyme and up to two missed cleavages were allowed. Score were thresholded so 
as to achieve a 1% FDR at the PSM, peptide, and protein levels as estimated by a decoy 
database. Match-between-runs, iBAQ, and LFQ quantitation were enabled. 
 
BLAST 
      Each protein sequence in the ESP was BLASTed against NCBI using BLASTp search 
with the following parameters: BLAST expectation value (e-value) 1.0E-3, number of 
BLAST hits 20, HSP length cutoff 33. 
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Bioinformatics 
       The protein sequences were further searched against Pfam search (version 32.0) with 
HMMER3 [36], SignalP (version 5.0) [28], [29], InterProScan [22], dbCAN2 for 
automated Carbonhydrate-active enzyme annotation [38]. Gene Ontology (GO) terms of 
molecular function, cellular component and biological process were assigned by 
transferring the GO terms from the top BLAST hit, mainly C. elegans orthologues. 
Blast2GO was used to add more GO and InterProScan results [5], [6].  
 
BLAST map 
        The C. elegans and C. inopinata ESPs BLAST map was created similarly to [43]. All-
to-all BLAST [44] was performed with C. elegans ESPs and C. inopinata identified in this 
work, with a threshold of E-value < 0.1. The map was created using igraph package in R 
[45]. Edges between nodes (proteins) were plotted as percent identity scores, scaled 
between 0 and 1, in a force-directed graph. Nodes without edges were removed from the 
graphs. Annotations for protein classes were pulled from WormBase [46] and Uniprot [47]. 
 
Orthologues and phylogenetic tree construction  
      In order to compare orthologues between two species, Orthofinder version 2.3.1 was 
used to assign proteins from two species into different orthologous groups [39]. Maximum-
likehood phylogenetic trees were constructed to interesting gene families by first doing 
multiple sequence alignment using EMBL-EBI MUSCLE [48]. The aligned sequences 
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were further trimmed by Trimal (v1.4.rev15) [49]; FastTree (2.1.7) [50], [51] and FigTree 
1.4 [52] were followed to construct and view the phylogenetic trees. 
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4.6 Figures 
 
Figure 4.1 Workflow of functional annotation of C. inopinata ESPs. Each entry was 
first BLASTed against NCBI then followed by searching InterProScan and Gene Ontology. 
The results from different databases were mapped and merged.  
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Figure 4.2 Statistics for annotation levels of C. inopinata ESPs.  (A) Length distribution 
of Mass-Spec identified excreted/secreted proteins. (B) Number of sequences in each level 
of annotations. (C) Pie chart of sequences annotated to different levels.  (D) Bar chart of 
sequences annotated to different levels. 
 157 
 
 
 158 
Figure 4.3 Statistics for BLAST performed to each C. inopinata ESP. (A) High-scoring 
Segment Pair (HSP)/Hit coverage distribution. (B) High-scoring Segment Pair (HSP)/Seq 
Coverage distribution. (C) Statistic for number of HSP in each Hit. (D) Statistic for number 
of Hits returned in each sequence. (E) Statistic for positive/alignment-length in each Hit. 
(F) Statistic for e-value for each Hit. 
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Figure 4.4 Species distribution of BLAST results of C. inopinata ESPs. (A) Species 
distribution for all BLAST Hits. (B) Species distribution for only top BLAST Hits. 
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Figure 4.5 GO terms distribution of C. inopinata ESPs (A) Statistics for number of GO 
terms annotated to each sequence (B) GO-level distribution. P = biological process, F =  
molecular function, C = cellular component. 
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Figure 4.6 Count of biological process GO terms of C. inopinata ESPs 
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Figure 4.7 Count of molecular function GO terms in C. inopinata ESPs 
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Figure 4.8 KEGG pathways annotated to C. inopinata ESPs 
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Figure 4.9 Structure of C. inopinata Excretome/Secretome. Pie chart described the 
distribution of protein families  
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Figure 4.10 InterPro family distribution of annotated C. inopinata ESPs. 
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Figure 4.11 InterPro domain distribution of annotated C. inopinata ESPs. 
 
 
 
 
 
 
 
 
 
 
 
InterProScan Domains Distribution [C. inopinata_ESP]
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Figure 4.12 Annotated enzymes in C. inopinata excretome/secretome. (A-F) detailed 
distribution for each identified enzyme class. A, ligases. B, isomerases. C, lyases. D, 
Hydrolases. E, Transferases. F, Oxidoreductases. (G) Distribution of six identified enzyme 
classes in C. inopinata excretome/secretome 
A B 
C D 
E F 
G 
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Figure 4.13 BLAST map of combined C. inopinata ESPs and C. elegans ESPs. All ESP 
sequences from two species were BLASTed in all-against-all manner. Edges indicate 
similarity by BLAST, with an E-value < 0.1. Proteins of C. inopinata origin were yellow 
dots and Proteins of C. elegans origin were circles. Color-coded are the ten protein classes 
with the highest numbers among the ESPs. 
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Figure 4.14 Phylogenetic relationships of nematodes based on ESPs similarities and 
SSU. Left side is the reconstructed phylogenetic tree of five nematodes based on 
excretome/secretome similarities. Right side is the phylogenetic tree constructed by 
comparing small subunit (SSU). This figure is modified from [13].  
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4.7 Tables  
 
Table 4.1 The top 30 abundant excreted/secreted proteins identified in Mass-Spec 
BLASTp search against NCBI was done to each protein. GO terms was assigned by 
Blast2GO. F, molecular function; P, biological process; C, cellular component. 
 
 
 
 
 
 
 
SeqName' Descrip.on' GONames'
Sp34_scaﬀold1.g1606.t13 444NA4443 F:kinase3ac=vity3
Sp34_scaﬀold1.g286.t13 nematode3cu=cle3collagen3domain3 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold1.g521.t13 Hypothe=cal3protein3CBG173443 C:nucleus3
Sp34_scaﬀold10.g799.t13 lipocalin3cytosolic3faNy4acid3binding3 F:transporter3ac=vity;3P:transport;3F:lipid3binding3
Sp34_scaﬀold11.g164.t13 hypothe=cal3protein3CRE_273873 C:integral3component3of3membrane3
Sp34_scaﬀold11.g641.t13 1443433zeta3 F:protein3domain3speciﬁc3binding3
Sp34_scaﬀold12.g432.t13 Ani3s393allergen3precursor3 P:response3to3gamma3radia=on3
Sp34_scaﬀold12.g8.t13 Fructose4bisphosphate3aldolase323 F:fructose4bisphosphate3aldolase3ac=vity3
Sp34_scaﬀold13.g705.t13 cysta=n3domain3 F:cysteine4type3endopep=dase3inhibitor3ac=vity3
Sp34_scaﬀold14.g122.t13 pep=dyl4prolyl3cis4trans3cyclophilin4type3 P:protein3pep=dyl4prolyl3isomeriza=on;3P:protein3folding3
Sp34_scaﬀold16.g122.t13 444NA4443 F:aspar=c4type3endopep=dase3ac=vity;3P:proteolysis3
Sp34_scaﬀold17.g183.t13 Invertebrate3LYSozyme3 F:lysozyme3ac=vity;3P:carbohydrate3metabolic3process3
Sp34_scaﬀold17.g64.t13 DAF4163FOXO3germline3Tumor3aﬀec=ng3
Sp34_scaﬀold18.g27.t13 Phosphoenolypyruvate3inase3 F:phosphoenolpyruvate3carboxykinase3(GTP)3ac=vity3
Sp34_scaﬀold2.g513.t13 transla=on3ini=a=on3factor3eIF45A3 F:transla=on3elonga=on3factor3ac=vity;3C:ribosome3
Sp34_scaﬀold3.g1197.t13 nematode3cu=cle3collagen3domain3 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold3.g521.t13 444NA4443 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold4.g1259.t13 major3allergen3 C:extracellular3region3
Sp34_scaﬀold4.g194.t13 444NA4443
Sp34_scaﬀold4.g202.t13 444NA4443
Sp34_scaﬀold4.g400.t13 COLlagen3 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold4.g742.t13 collagen3 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold4.g945.t13 muscle3ac=n3 F:isopentenyl4diphosphate3delta4isomerase3ac=vity;3
Sp34_scaﬀold5.g421.t13 444NA4443 C:Golgi3apparatus3
Sp34_scaﬀold6.g436.t13 heat3shock3703
Sp34_scaﬀold7.g282.t13 MD424related3lipid4recogni=on3domain4containing3
Sp34_scaﬀold7.g656.t13 Major3sperm319331340345350351353359361365381311331423
Sp34_scaﬀold7.g776.t13 nematode3cu=cle3collagen3domain3 F:structural3cons=tuent3of3cu=cle3
Sp34_scaﬀold8.g126.t13 444NA4443 F:transla=on3elonga=on3factor3ac=vity;3
Sp34_scaﬀold8.g185.t13 444NA4443 F:lipid3binding3
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Table 4.2 The list of carbohydrate active enzymes in the excretome/secretome of C. 
inopinata 
 
 
 
 
 
 
 
 
 
 
Gene_ID' HMMER' Hotpep' DIAMOND' Signalp' #ofTools'
Sp34_scaﬀold1.g2282.t13 GH18(569404)3 GH183 CBM143 Y(1925)3 33
Sp34_scaﬀold1.g2610.t13 GH30_1(899487)3 GH303 GH30_13 N3 33
Sp34_scaﬀold1.g2795.t13 GT31(809264)3 GT313 GT313 N3 33
Sp34_scaﬀold10.g308.t13 GH25(379207)3 N3 N3 Y(1927)3 13
Sp34_scaﬀold11.g356.t13 CE10(4959750)3 N3 N3 N3 13
Sp34_scaﬀold11.g530.t13 GH152(269233)3 N3 GH1523 N3 23
Sp34_scaﬀold11.g531.t13 GH152(269233)3 N3 GH1523 Y(1925)3 23
Sp34_scaﬀold17.g112.t13 GT35(1459839)3 GT353 GT353 N3 33
Sp34_scaﬀold3.g321.t13 GH13_8(5589851)3 GH13+CBM483 CBM483 N3 33
Sp34_scaﬀold4.g1177.t13 GT1(3759559)+GT1(98591156)+GT1(146491635)3 N3 GT13 N3 23
Sp34_scaﬀold4.g26.t13 CE10(719231)3 N3 N3 N3 13
Sp34_scaﬀold4.g646.t13 GH19(599361)3 GH193 GH193 Y(1924)3 33
Sp34_scaﬀold6.g140.t13 GH152(599231)3 N3 N3 N3 13
Sp34_scaﬀold9.g638.t13 GH31(699572)3 GH313 GH313 N3 33
Sp34_scaﬀold17.g183.t13 N3 GH223 N3 Y(1919)3 13
Sp34_scaﬀold2.g18.t13 N3 GH223 N3 Y(1919)3 13
Sp34_scaﬀold9.g503.t13 N3 GT13 N3 N3 13
Sp34_scaﬀold10.g536.t13 N3 N3 GT133 N3 13
Sp34_scaﬀold12.g107.t13 N3 N3 GH253 N3 13
Sp34_scaﬀold19.g285.t13 N3 N3 CBM133 N3 13
Sp34_scaﬀold1.g1713.t13 N3 N3 CBM143 N3 13
Sp34_scaﬀold4.g685.t13 N3 N3 GH253 N3 13
Sp34_scaﬀold7.g104.t13 N3 N3 GT223 N3 13
Sp34_scaﬀold9.g363.t13 N3 N3 GT303 N3 13
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Table 4.3 Statistics of orthogroup assignments between C. inopinata and C. elegans 
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Table 4.4 Top 20 orthogroups between B. xylophilus and C. elegans. Numbers represent 
the count of genes in each category. 
!! Bursaphelenchus!xylophilus_ESP!
Bursaphelenc
hus!
xylophilus_ES
P! Celegans_ESP! Celegans_ESP! Total!
OG0000000$
BUX.c07587.1,$BUX.s00083.30,$
BUX.s00083.31,$BUX.s00083.32,$
BUX.s00116.607,$BUX.s00713.1009,$
BUX.s00713.1010,$BUX.s00713.1011,$
BUX.s00713.1016,$BUX.s00713.1034,$
BUX.s00713.1076,$BUX.s00813.52,$
BUX.s00813.53,$BUX.s00813.54,$
BUX.s01063.86,$BUX.s01109.631,$
BUX.s01147.156,$BUX.s01147.175,$
BUX.s01147.176,$BUX.s01147.177,$
BUX.s01147.64,$BUX.s01259.43,$
BUX.s01259.45,$BUX.s01288.15$ 24$ CELE_Y40H7A.10$ 1$ 25$
OG0000001$
BUX.s00508.67,$BUX.s00508.71,$
BUX.s00974.24,$BUX.s01198.139,$
BUX.s01198.141,$BUX.s01198.143,$
BUX.s01281.328,$BUX.s01281.329,$
BUX.s01337.113,$BUX.s01337.114,$
BUX.s01653.360$ 11$ CELE_T16G12.1$ 1$ 12$
OG0000002$ BUX.s00110.75$ 1$
phatA1,$phatA2,$C14C6.2,$C14C6.5,$C54D10.3,$CELE_F15A4.6,$
CELE_F41G3.10,$CELE_F48G7.5,$ZK673.1,$$ 9$ 10$
OG0000003$
BUX.s00560.3,$BUX.s00609.105,$
BUX.s01063.177,$BUX.s01063.193,$
BUX.s01063.6,$BUX.s01063.7$ 6$ FrA18,$FrA59$ 2$ 8$
OG0000004$
BUX.s00116.457,$BUX.s00647.119,$
BUX.s00647.122,$BUX.s00961.40,$
BUX.s00961.41,$BUX.s00961.42,$
BUX.s01254.333$ 7$ gstA1$ 1$ 8$
OG0000005$ BUX.s01143.209$ 1$ aspA1,$aspA10,$aspA12,$aspA13,$aspA2,$aspA5,$aspA6$ 7$ 8$
OG0000006$
BUX.s00116.908,$BUX.s00139.52,$
BUX.s01092.201,$BUX.s01281.110,$
BUX.s01281.237,$BUX.s01281.52$ 6$ mspA49$ 1$ 7$
OG0000007$
BUX.s00139.135,$BUX.s01063.66,$
BUX.s01063.80,$BUX.s01661.62,$
BUX.s01661.67$ 5$ nepA17$ 1$ 6$
OG0000008$
BUX.s01143.109,$BUX.s01143.142,$
BUX.s01281.44$ 3$ FrA44,$FrA45,$FrA51$ 3$ 6$
OG0000009$
BUX.s00333.141,$BUX.s00422.384,$
BUX.s01078.13,$BUX.s01109.44,$
BUX.s01109.45$ 5$ cutlA16$ 1$ 6$
OG0000010$ BUX.s00252.35,$BUX.s00333.33$ 2$ C10G8.4,$C25E10.8,$CELE_F53C11.9,$swmA1$ 4$ 6$
OG0000011$ BUX.s01268.52,$BUX.s01662.95$ 2$ vitA2,$vitA5,$vitA6$ 3$ 5$
OG0000012$
BUX.s01063.203,$BUX.s01063.204,$
BUX.s01063.205,$BUX.s01063.206$ 4$ F37H8.5$ 1$ 5$
OG0000013$
BUX.c00054.1,$BUX.s01066.1,$
BUX.s01066.3,$BUX.s01066.8,$
BUX.s01505.4$ 5$ 0$ 5$
OG0000014$ BUX.s01281.46$ 1$ gpdA1,$gpdA2,$gpdA3,$gpdA4$ 4$ 5$
OG0000015$
BUX.s01038.28,$BUX.s01653.296,$
BUX.s01653.306,$BUX.s01653.308$ 4$ colA90$ 1$ 5$
OG0000016$ BUX.s01109.74$ 1$ C39D10.7,$CELE_R02F2.4,$cpgA1,$cpgA2$ 4$ 5$
OG0000017$
BUX.s00351.323,$BUX.s00351.324,$
BUX.s00351.325$ 3$ pdiA1$ 1$ 4$
OG0000018$ BUX.s00422.202$ 1$ farA1,$farA2,$farA3$ 3$ 4$
OG0000019$
BUX.s00579.461,$BUX.s00713.520,$
BUX.s01656.92$ 3$ ancA1$ 1$ 4$
OG0000020$
BUX.s00579.226,$BUX.s01109.465,$
BUX.s01653.34$ 3$ tbbA2$ 1$ 4$
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